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ABSTRACT OF DISSERTATION 
BIOBEHAVIORAL INFLUENCES OF ANXIETY, DEPRESSION,  
AND HOSTILITY SYMPTOMS ON HEALTH-RELATED OUTCOMES 
IN PATIENTS WITH HEART FAILURE 
The incidence of heart failure (HF) has increased each year as more people are 
living longer with heart disease and other chronic conditions. Recently, there has been 
much interest in the psychological dimensions of HF and the influence psychological 
symptoms have on the health outcomes (e.g., self-care, rehospitalization, mortality and 
quality of life) of patients living with HF. Patients with HF frequently experience 
symptoms of anxiety, depression, and hostility that may be associated with poor health 
outcomes. The purpose of this dissertation was to examine how psychological variables 
influence health outcomes of patients with HF, how psychological variables change over 
time, and whether different trajectories of psychological variables are associated with 
health outcomes. The specific aims of this dissertation were to: (1) evaluate the 
psychometric properties of the Brief Symptom Inventory (BSI) Hostility subscale in 
patients with HF; (2) determine whether anxiety, depression, and hostility predict self-
reported self-care behaviors in patients with HF; and (3) describe trajectories of anxiety 
and depressive symptoms among patients with HF at baseline and 3 and 12 months post-
baseline, and explore whether these symptom trajectories predict 1-year cardiac event-
free survival and physical health-related quality of life (P-HRQOL). 
Secondary analyses of longitudinal data from a large, multi-region registry 
representing the Midwest, Southwest, Southeast, Northwest and Northeast United States 
(Heart Failure Quality of Life Trialists Collaborative) were conducted. Data from three 
subsets of participants enrolled in the Collaborative with complete data on the variables 
of interest comprised the samples for the three studies in this dissertation. In the first 
study, a psychometric evaluation of the BSI Hostility subscale was conducted using data 
from 345 patients with HF. The subscale demonstrated adequate internal consistency 
reliability (Cronbach’s alpha = .77) and construct validity. In the second longitudinal 
study of 214 patients with HF, baseline anxiety, depression, and hostility did not predict 
self-reported self-care at 12 months; however, higher perceived social support predicted 
greater levels of self-reported self-care. In the third study, baseline, 3-month, and 12-
month data from 597 patients with HF were used to examine the association of anxiety 
and depression trajectories with one-year cardiac event-free survival and P-HRQOL in 
patients with HF.  Distinct trajectories of anxiety and depression predicted mortality, 
hospital readmission, and P-HRQOL. 
The findings of these studies filled some gaps in our understanding regarding how 
anxiety, depression, and hostility influence health outcomes of patients with HF. The 
findings suggest how a measure of hostility may be improved to assess hostility in 
patients with HF and the importance of assessing psychological symptoms routinely in 
order to identify changes in these symptoms. Results showed that psychological variables 
did not predict self-reported self-care, a component of risk reduction in improving health 
outcomes among patients with HF, but that social support, an important psychosocial 
variable, was a strong predictor of self-reported self-care. Trajectories of psychological 
variables were significant predictors of health outcomes in patients with HF at 1-year 
follow-up.  Implications include the importance of monitoring psychological symptoms 
over time. A better understanding of how psychological symptoms change is meaningful, 
as it affords clinicians the opportunity for timely interventions designed to reduce the risk 
of adverse events and improve health outcomes. Even though numerous studies exist 
which examine psychological symptoms and health outcomes in patients with HF, there 
are very few longitudinal studies investigating trajectories of psychological symptoms in 
this population.  Subsequently, more research is needed to investigate psychological 
symptom trajectories and identify high risk groups. In addition, the design and testing of 
interventions aimed at reducing psychological symptoms is critical to improve health 
outcomes in patients with HF.  
KEYWORDS:  heart failure, anxiety, depression, hostility, trajectories, psychological 
symptoms 
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Chapter One: Introduction 
For over 2000 years people have written about the connection between emotions 
and physical health.1,2 Since antiquity strong negative emotions have been associated 
with cardiopulmonary symptoms to the extent that many believed the heart was the center 
of emotions.3 Egyptians believed the heart was the seat of human wisdom, emotions, and 
life itself - a place where the soul resided - and when the dead were judged, the heart was 
weighed against the feather of truth to determine if the deceased could enter the afterlife.4 
While the heart is not the center of emotions as once believed, it is clearly affected by 
psychological conditions. Studies have shown that negative emotions, such as anxiety, 
depressive symptoms, and hostility, increase the risk of the development and progression 
of cardiovascular disease5-7 and subsequent heart failure (HF).8-13  
Currently more than 5,700,000 people in the United States suffer from HF, and an 
estimated 870,000 new cases are diagnosed each year.14 The prevalence of HF has 
continued to increase annually as more people survive longer with cardiovascular disease. 
It is estimated that the prevalence of HF will increase 46% from 2012 to 2030.14 This 
steady rise in HF has important implications for healthcare. In addition to a variety of 
physical symptoms, patients with HF suffer from psychological distress that impacts 
survival and quality of life.15 The relationships between these negative emotions and HF 
are multidimensional, complex, and poorly understood. However, research suggests 
negative emotions affect health outcomes of patients of living with HF. 9,16-19 
Patients with HF experience higher levels of anxiety, depressive symptoms, and 
hostility than their healthy elder counterparts or patients with other cardiac conditions.20 
Negative emotions may lead to pathophysiological changes that subsequently increase 
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risk of clinical events21 and can complicate cardiovascular disease in general.22 The 
clinical risks associated with negative emotional states in cardiac patients may be equal to 
or greater than those associated with traditional risk factors such as diabetes and smoking. 
Heart failure patients who have negative emotional states have poorer health-related 
quality of life (HRQOL),23-25 decreased adherence to treatment regimens,26-29 and higher 
rates of hospitalization30 and mortality.31-33,34  
However, research concerning the incidence, prevalence, and health outcomes 
associated with symptoms of anxiety, depression, and hostility among patients with 
cardiovascular disease and HF has yielded varying results.20,35 This may be attributed to 
the different ways these negative emotional states have been defined, heterogeneity of 
patients in subgroups of cardiac disease, and the methods used to screen for their 
presence.36,37  
Conceptual Dimensions of Anxiety, Depressive Symptoms, and Hostility  
Anxiety. Anxiety is a negative affective state; however, it is often used as an 
umbrella term for a variety of disorders.38 It has been difficult to define the conceptual 
dimensions of anxiety, as researchers often use the term loosely to describe various 
psychiatric conditions (i.e. panic disorder, post-traumatic stress disorder, generalized 
anxiety disorder, obsessive compulsive disorders, and specific phobias)39 as well as a 
normal transient emotional experience.40 Additional ambiguity exists in defining anxiety, 
as anxiety has often been studied as either trait anxiety or state anxiety41,42  
Trait anxiety refers to the predisposition of an individual to experience anxiety, 
and state anxiety refers to the actual experience of anxiety that is manifested by a 
transitory emotional reaction to a situation that is accompanied by a physiological 
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response.43,44 Therefore, trait anxiety is considered a personality dimension of 
neuroticism rather than emotional stability45 and is suggestive of an enduring 
predisposition of an individual to respond to many threatening situations in a relatively 
consistent manner.44  
Despite the different conceptual definitions of anxiety, a shared characteristic of 
all anxiety disorders is that anxiety is a complex subjective human experience in response 
to a foreboding dread or perceived threat that has physiological, behavioral, affective, and 
cognitive symptoms.46,47,48 A majority of the symptoms of anxiety are physical in nature 
and occur as a result of activation of the sympathetic nervous system (SNS) and 
parasympathetic nervous system (PNS), of which activation of the SNS is the 
predominate physiological response.48 Physical symptoms of anxiety include increased 
heart rate, palpitations, nausea, sweating, shaking, breathlessness, hyperventilation, 
diarrhea, and tingling and numbness in the mouth and arms, and may result in behaviors 
that include agitation, avoidance, and withdrawal.40,48 The affective and cognitive 
reactions of anxiety include symptoms of restlessness, agitation, fearfulness, feelings of 
helplessness and of being overwhelmed as well as worrying, recurrent unpleasant 
thoughts, poor concentration, confusion, narrowing of attention, hypervigilance for any 
threat, poor memory, and difficulty in reasoning.40,48  
The severity of anxiety symptoms exists on a continuum ranging from normal to 
pathological depending on subjective perception, intensity, duration, sense of control, and 
subsequent dysfunction or interference with life activities.48-50 Some symptoms of anxiety 
serve a useful purpose insofar as the physiological changes often seen in anxiety are 
responses that prepare the body both mentally and physically to react to situations that are 
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perceived as dangerous. The perception of danger elicits a fear response that results in 
autonomic arousal and the subsequent ability and motivation to respond to or confront 
that danger.40,48 Therefore, both fear and anxiety are considered adaptive processes to 
threats of danger. 
Although fear and anxiety are adaptive states which function to preserve life, 
some researchers use these terms interchangeably.51 Part of the confusion lies in the fact 
that the physiological responses to fear and anxiety are similar with SNS arousal and 
subsequent symptoms. Fear and anxiety have been differentiated by some52 with fear 
being defined as the intellectual appraisal of danger and anxiety being defined as the 
emotional response to that appraisal. However, a growing body of evidence supports the 
premise that fear and anxiety are different emotions and constructs conceptually.51 The 
neuroscience literature suggests fear is a response to a perception of a specific threat,53 
while anxiety is viewed as a prolonged hypervigilance in response to a diffuse threat that 
is not specific or clearly imminent.54 
Anxiety and specific anxiety disorders are commonly diagnosed by a medical 
health professional from an interview process. However, many studies use symptoms of 
state or trait anxiety as determined by self-report scales such as the Brief Symptom 
Inventory (BSI) Anxiety Subscale,55,56 the Spielberger State-Trait Anxiety Inventory 
(STAI),57 Beck Anxiety Inventory (BAI),58 and the Hospital Anxiety and Depression 
Scale-Anxiety (HADS-A).59 I chose to measure state anxiety with the BSI Anxiety 
Subscale in the three studies included in this dissertation. The BSI Anxiety Subscale is a 
short 6-item self-report questionnaire55 that can be used to assess symptoms of anxiety. 
The self-report questionnaire is easy to administer and does not create undue burden on 
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patients with HF who may experience symptoms such as fatigue. The BSI has been used 
in numerous populations56,60 and has good internal consistency and excellent validity in 
several samples of patients with HF.26,61,62 
Depressive symptoms. Depression has resulted in more human suffering than 
any other disease affecting mankind.63,64 It is considered a disorder of mood characterized 
by the presence of a number of symptoms which interfere with a person’s ability to carry 
out activities of daily living as outlined in The ICD-10 Classification of Mental and 
Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines (ICD 10)65 and 
the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.66 In order to meet 
the definition for a major depressive disorder, a person must experience at least five of 
the following nine symptoms over a two-week period of time: 1) depressed mood most of 
the day; 2) markedly diminished interest or pleasure in most activities; 3) significant 
weight loss or weight gain; 4) inability to sleep or oversleeping most days; 5) fatigue or 
loss of energy; 6) psychomotor agitation or retardation; 7) feelings of worthlessness or 
excessive or inappropriate guilt; 8) decreased ability to think or concentrate, or 
indecisiveness; or 9) recurrent thoughts of death. For a diagnosis of clinical depression, 
one of the symptoms must include either depressed mood or loss of interest or pleasure in 
activities.39 Together, these symptoms represent the core symptoms of depression.67  
However, there is some controversy as to how depression should be 
conceptualized apart from a clinical diagnosis. Individuals with depression often 
complain of an unpleasant emotional state, a changed attitude toward life and loss of 
interest in activities, somatic symptoms typical of depression (e.g. fatigue, leaden 
paralysis, loss of appetite), and somatic symptoms not typical of depression (e.g. 
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headache, constipation).39,68 An interesting phenomenon in depression is that a majority 
of patients experience a disturbance in self-concept and negative view of themselves that 
is in stark contrast from the objective assessment a clinician may make.64 This has led to 
the belief that depression is primarily an affective disorder. However, researchers have 
demonstrated that depressed patients often complain of physical symptoms regardless of 
whether they have a mental or physical illness.64,68,69 The variety of symptoms seen in 
depression as well as the various semantics used have resulted in difficulty 
conceptualizing depression.  
From time to time many individuals complain of feeling ‘depressed’ without any 
low mood, sadness, or clinical diagnosis.64 Loose use of the term depression in everyday 
language as well as the use of the term to describe symptoms or a psychopathology 
makes conceptualizing depression challenging as depression is used to describe numerous 
feelings or symptoms, a symptom-complex (syndrome), or a specific disease entity.64 
Symptoms of depression may range from transitory feelings of ‘being down’ to a specific 
psychopathology such as major depressive disorder (MDD) or bipolar disorder. However, 
deviations in feelings, cognition, and behavior are seen most often when the term 
depression is used.64,69 
Thus, depression is best described as the presence of symptoms that are 
syndromal in nature, implying that there is cluster of symptoms that occur together 
ranging in intensity.64,67 These depressive symptoms occur along a spectrum of increasing 
severity of symptoms which range from non-specific symptoms that are not indicative of 
a disorder to a diagnosis of major clinical depression.70-73 In fact, patients can have very 
distressful depressive symptoms without having an actual diagnosis of MDD.74 Screening 
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for depressive symptoms allows for greater understanding of subclinical depression70 as 
well as residual depression where patients have been treated but still have symptoms of 
depression. This is important for improving health outcomes as residual depression may 
represent persistence of a milder form of depression or signal increased risk of relapse.75 
Depressive symptoms may be screened through a clinical interview, review of a 
patient’s medical record, or depression symptom inventories which include self-report 
measures.19 Self-report measures have been criticized as they depend on patient memory, 
honesty, and potential desire of the patient to be viewed favorably. However, in a meta-
analysis of 27 studies reporting depression rates among patients with HF, Rutledge et 
al.19 found prevalence rates for depression varied from 10% to 54% depending on the 
method of assessment used. Those studies using self-report had substantially higher 
prevalence rates than those studies that utilized clinical interview combined with self-
report or clinical interview alone. This would suggest that self-report measures might be 
more sensitive in identifying depressive symptoms that are troublesome to patients. 
Several self-report questionnaires are available for assessing depressive symptoms 
including the Beck Depression Inventory (BDI),76 Center for Epidemiological Studies-
Depression Scale,77 BSI Depression Scale,55,56 and the Patient Health Questionnaire-9 
(PHQ-9).78,79 I chose to use the PHQ-9 to measure depressive symptoms in all three 
studies comprising this dissertation. The PHQ-9 is a self-report measure composed of 
nine Likert scale items that reflect the symptom criteria outlined for depressive 
disorders.73,78 The PHQ-9 is short, easy to administer, and has excellent reliability and 
validity in numerous patient populations79,80 as well as in samples of patients with 
HF.62,81 
 
 
8 
 
 
Hostility. Hostility is a multidimensional construct that has cognitive, affective, 
and behavioral components. It has been defined as a negative attitude or personality trait 
that is directed toward others37 and characterized by a belief that others are unworthy, 
underserving,82 and immoral.83 The concept of hostility has been confusing to define as it 
is associated with other phenomenon such as anger and aggression.37 These constructs are 
closely related negative psychological constructs that are often thought of as being one 
and the same and sometimes used interchangeably in research.37,84,85 While several 
studies have demonstrated strong correlations between hostility scales and trait anger86 
and aggression scales, these constructs are different. However, defining and 
differentiating these constructs can be challenging as some of the personality factors 
related to hostility, anger, and aggression are similar.37,87 
The constructs of hostility, anger, and aggression are best understood by 
examining the emphases on components of cognition, affect, and behavior.88 The 
cognitive component of hostility entails a negative attitude toward others consisting of ill 
will, enmity, and denigration.89 Hostility also includes components of cynicism, mistrust, 
and a biased attributional style83,89,90 This sense of mistrust results in an expectancy that 
people will not fulfill obligations and are frequent sources of provocation, mistreatment, 
and even harm.89 The cynicism of hostile individuals makes them more likely to believe 
that others are motivated by selfish concerns rather than by a genuine concern for 
others.89 Together, these beliefs produce a biased attributional style leading hostile 
individuals to interpret the actions of others as antagonistic or threatening, thus making 
the hostile individual more likely to respond to others in an aggressive or antagonistic 
manner.91  
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In addition, the affective component of hostility includes numerous emotions such 
as anger, annoyance, resentment, disgust, and contempt.83,92-94 The behavioral component 
of hostility may include acts of overt aggression, subtle aggression, and verbal 
aggression.83 Thus, a hostile individual may respond to the acts of others with frustration 
and anger and behave in a physically aggressive manner or exhibit verbal aggression 
through hateful insults, opposition to others, rudeness, sarcasm, or argumentativeness.89,95 
Therefore, as a general trait, hostility involves a devaluation of the worth of others and 
interpersonal suspicion and mistrust of the motives of others. These beliefs result in an 
expectation that others are likely sources of wrongdoing, and there is also a desire to 
inflict harm or see others harmed.89,96 
Anger, on the other hand, is an affective construct that is characterized by an 
unpleasant emotion that may range in intensity from irritation or annoyance to fury or 
rage.97,98 It can be defined as either a state or a trait. The state of or experiential 
component of this emotion is usually accompanied by physiological arousal and 
activation of tendencies toward aggression.97 Anger is also characterized by a relational 
theme whereby the angry individual has the perception of being subjected to illegitimate 
or unfair interference or harm.50,99 Therefore, the experience of anger is a subjective 
process with related emotions of contempt and resentment similar to hostility.89,98 Anger, 
as a trait, is the tendency of an individual to experience states of anger with greater 
frequency, over a wider range of situations, and over longer periods of time.87,91,100 The 
behavioral component of anger includes concepts of anger expression and anger-coping 
styles and refers to the extent to which people express or display feelings of anger. 
Anger-out is the tendency an individual possesses to openly express anger and typically 
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involves some type of aggression while anger-in is tendency to suppress or deny 
anger.91,101  
Both hostility and anger share traits of aggression in terms of behavioral 
components. However, aggression is usually associated with behaviors directed to harm 
another and may range from verbal to physical attacks. Physical aggression can be direct, 
indirect, or passive.89 Common behaviors associated with aggression include demeaning 
remarks, sarcasm, intimidating glares, rolling of eyes, hateful insults, rudeness, and 
confrontation.89,91 Thus, aggression can be viewed as an antagonistic behavior that is one 
aspect of the behavioral component of hostility.83  
Hostility, however, involves a more complex cognitive component than anger or 
aggression. The prominent characteristic in hostility is one of cynicism. While anger has 
a cognitive component, the more overriding component is the affective or emotional 
component, and aggression’s most prominent feature is that of behavior. Therefore, in 
conceptualizing hostility, the three attributes of cynicism, anger, and aggression may be 
present together with hostility or in the absence of the other two constructs.83 
Hostility has been measured using an assortment of self-report measures such as 
the Cook-Medley Hostility Subscale,90,102 the Buss-Durkee Hostility Inventory,92,103 and 
the BSI Hostility Subscale.55,56,60 I used the BSI Hostility Subscale in two of the studies 
in this dissertation as it is a short 5-item self-report survey that asks questions about 
symptoms of hostility experienced by patients in the last two weeks that occur within the 
three dimensions associated with the concept of hostility: thoughts, feelings, and 
behavior.60 While hostility is a concept frequently measured in the cardiac population, it 
is not routinely measured in patients with HF. Part of the problem may be the issue of 
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conceptualizations of hostility versus anger and aggression. In addition, most measures of 
hostility have greater than 50 items that may create undue fatigue among patients with 
HF. The BSI Hostility Subscale is the briefest hostility measure available and is very easy 
for clinicians to administer;104 therefore, its use and application in studies of patients with 
HF is ideal. The BSI Hostility Subscale has been used in many populations,60 and has 
good internal consistency and validity in patients with HF.105,106 
Influence of Symptoms of Anxiety, Depression, and Hostility on Health Outcomes 
Numerous studies have demonstrated a strong association between negative 
emotional states and the development and progression of cardiovascular disease.2,107-110 
However, the mechanisms linking anxiety, depressive symptoms, and hostility with 
adverse health outcomes in patients with HF are not well established. Negative emotional 
states may worsen or be a risk factor for HF, or HF may exacerbate symptoms of anxiety, 
depression, or hostility, or these negative emotions may interact with HF.16 However, 
several mechanisms through which negative emotional states may convey increased 
cardiovascular risk and worsening of HF have been proposed. Currently, there are two 
primary potential pathways by which negative emotions increase the risk of adverse 
cardiovascular outcomes: (1) physiological hyperreactivity and (2) behavioral factors 
such as non-adherence to medical regimes, engagement of risky behaviors, and limited 
use of appropriate health-related resources (Figure 1.1).26,109,111-123 The extent to which 
symptoms of anxiety, depression and hostility influence the two potential pathways can 
be mediated or moderated by individual vulnerability factors such as age, sex, 
comorbidities, perceived social support, education, and functional ability (Figure 1.1). 
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Potential physiological hyperreactivity. Negative emotions have been 
associated with the development of cardiovascular disease through a direct physiologic 
effect that results in dysregulation of the autonomic nervous system (ANS) that initiates a 
cascade of events that confer increased risk.7,124,125 The influence of negative emotions 
may cause a similar physiological hyperreactivity in patients with HF which results in 
worsening HF, decreased physical health-related quality of life (P-HRQOL), increased 
hospitalizations, and increased mortality (Figure 1.1).126 
Dysregulation of the autonomic nervous system. The ANS is responsible for 
regulating cardiovascular homeostasis through the SNS and the PNS. Negative emotional 
states produce alterations in ANS modulation causing activation of the SNS and 
inhibition or withdrawal of the PNS.126 These negative emotions produce physiological 
reactions that are excessive and prolonged and may explain the association of these 
emotions to poor health outcomes.2,110,127,128 Dysregulation of the ANS results in 
alteration of neurohumoral function and increased circulating levels of norepinephrine 
(NE) and epinephrine (E).18 Autonomic nervous system dysregulation has been shown to 
worsen HF and is a strong predictor HF progression,18 mortality, and sudden cardiac 
death.129  
Increased SNS activation from negative emotions in patients with HF can result in 
electrical instability of the myocardium that subsequently increases risk of ventricular 
arrhythmias due to inadequate opposition of SNS.130 Approximately 50% of patients with 
advanced HF experience sudden death thought to be attributable to ventricular 
dysrhythmias.131 Negative emotions are also associated with decreased heart rate 
variability (HRV) in patients with heart disease.132,133,134 Higher heart rate variability 
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reflects better balance between the SNS and the PNS and is a healthier state. The heart 
rate (HR) of healthy individuals varies in response to respiration and to changes in the 
physical demands of the body; however, negative emotions are associated with decreased 
HRV.135,136 Heart rate variability is considered a measure of cardiac autonomic 
innervation; therefore, decreased HRV is an indication of abnormal ANS modulation of 
HR, excessive sympathetic stimulation, and reduced vagal activity.132 Decreased PNS 
innervation exposes the heart to unopposed stimulation by the SNS and has been shown 
to be an independent predictor of morbidity and mortality in patients with HF.137  
Alteration of neurohormonal function. The ANS response to emotions differs 
according to the state of emotion.138,139 Positive emotion states increase PNS activity 
whereas negative emotional states result in activation of the SNS and subsequent 
inhibition or withdrawal of the PSN.138,140 When the SNS is activated, there are 
immediate changes in the neurohumoral, hematologic, endocrine, and vascular systems.3 
The subsequent hemodynamic and neurohumoral responses caused by the release of 
catecholamines, NE, and E, and further increases SNS activity.141-143 This initially results 
in increased HR, cardiac output, and blood pressure.141 However, patients with HF may 
have decreased clearance of NE due to compromised cardiac output resulting in further 
increased levels of NE.144 The presence of increased levels of NE and E may exacerbate 
HF symptoms as these catecholamines increase HR, increase contractility, and increase 
cardiac workload in patients with HF whose cardiac reserve is already compromised. 
Researchers have demonstrated that increased levels of NE and E are associated with 
adverse HF prognosis144,145 and predict mortality in patients with HF.146  
Norepinephrine plays a determinate role in executive function such as regulating 
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intellect, cognition, and motivation, and influences the ability to have social 
relationships147 while E helps to regulate cognition, attention, mental focus, and arousal. 
Executive functions are fundamental to problem-solving capacity in ways that are 
acceptable to the individual as well as society.147 These functions include the ability to 
suppress nonpertinent information, inhibit unacceptable behavior, and self-regulate 
affect, motivation, and arousal.147 Patients with negative emotional states have elevated 
serum and urinary levels of NE128,148-150 and E.135 The increased levels of NE and E may 
be associated with increased stimulation from the SNS and the stress response.128,151 
Negative moods may interfere with cognitive processes. Further, chronic stimulation of 
the stress response by the SNS leads to structural changes in the pre-frontal cortex (PFC) 
of the brain, where executive function is controlled.152 Highly elevated levels of NE can 
suppress neuronal firing in the brain and impair spatial working memory152 as well as 
leading to a relapse of maladaptive behaviors such as smoking, overeating, drinking 
alcohol, and drug addiction.153 The balance of neurotransmitters in the PFC is sensitive to 
change and may influence the behavioral pathway through its influence on self-care and 
maladaptive behaviors. 
Activation of the hypothalamic-pituitary-adrenal (HPA) axis. Negative emotional 
states are associated with reduced feedback control of the HPA axis with subsequent 
increased HPA activity.18,154,155 Increased HPA axis activity results in a sequence of 
events including signaling the hypothalamus to release corticotropin-releasing factor. 
Release of corticotropin-releasing factor increases corticotropin release from the pituitary 
and reduces adrenocorticotropin response to corticotropin resulting in increased cortisol 
levels and aldosterone from the adrenal cortex.156 This cascade of responses results in a 
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failure of the body’s normal feedback inhibition system such that cortisol levels remain 
high.157  
Increased cortisol levels are associated with hypertension,158 insulin resistance,159 
abdominal obesity,160 oxidative stress,161 altered endothelial function,162 
vasoconstriction,162 and inflammation.163 Increased cortisol levels may be associated with 
progression of HF and worse health outcomes.164,165 Increased cortisol levels may imitate 
the effects of aldosterone by binding with aldosterone’s receptor, the mineralocorticoid 
receptor and stimulating the effects of aldosterone. The subsequent increase in 
aldosterone conserves sodium, secretes potassium, and promotes water reabsorption 
thereby increasing blood volume and subsequent blood pressure adding to workload on 
the heart.166 Activation of the HPA axis by a failing ventricle in the presence of increased 
workload produces more cortisol and aldosterone which leads to further cardiac 
remodeling, thereby increasing the severity of HF.164 
Stimulation of the SNS, along with renal hypotension and decreased amounts of 
sodium delivered to the renal tubules, stimulates the release of renin and the further 
release of aldosterone by the renin-aldosterone-system (RAAS). Renin activates the 
conversion of angiotensin I to angiotensin II which causes vasoconstriction resulting in 
increased blood pressure as well as inhibition of the release and reuptake of NE. The 
increase in NE increases levels of antidiuretic hormone which also inhibits water 
excretion and further vasoconstriction, further contributing to myocardial remodeling.167 
In addition, cytokines, macrophages, and neutrophils are released due to the activation of 
RAAS. This results in the deposition of fibroblasts and collagen leading to ventricular 
hypertrophy, fibrosis, and heart remodeling.168 Negative mood states activate RAAS 
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through stimulation of SNS.168,169  
Increased activation of the HPA axis by negative emotions may contribute to 
decreased cognitive function observed in HF patients. Depressed patients have increased 
cortisol levels as studies indicate there is diminished negative feedback in the HPA 
axis.170 Extended exposure to elevated levels of cortisol has been shown to have adverse 
effects on verbal memory,171,172 and impaired performance in declarative memory and 
spatial thinking tasks173 among patients with depressive symptoms.  
Woo and colleagues174 examined magnetic resonance images (MRIs) of 9 patients 
with HF and 27 controls. Compared to the controls, patients with HF had reduced grey 
matter in areas associated with ANS control, areas essential for mediating pain, areas 
associated with autonomic regulation (important for multiple fluid, thermoregulatory, and 
sleep maintenance functions as well as ANS control), areas associated with depressive 
symptoms and mood regulation, and areas associated with cognition, behavioral 
performance, and mediating expressive aphasia. Woo et al.174 suggest mechanisms of 
injury to the brain may be ischemic, hypoxic, or inflammatory processes. The 
investigators suggest that patients with HF have structural changes in the brain that may 
compromise their ability to understand and adhere to medical regimens and the changes 
in brain structure may also have a role in the subsequent development of depressive 
symptoms.174 Almeida et al. examined the MRIs of 35 patients with HF and 56 patients 
with ischemic heart disease against 64 healthy individuals and found the patients with HF 
had evidence of loss of grey matter in various areas of brain and lower scores than the 
control group on immediate memory, long delay recall and digit coding.175 These studies 
illuminate the possibility that brain changes found in heart failure may influence the 
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ability of patients with HF ability to care for themselves, take medications, and keep 
medical appointments.  
Activation of cytokine cascade. Inflammation and changes in the immune system 
occur through activation of the HPA axis and the ANS via the outflow pathways of the 
central nervous system. Increased release of corticotropin hormone occurs in response to 
negative emotions that results in the release of pro-inflammatory cytokines.176 Numerous 
studies have documented the effects anxiety, depressive symptoms, and hostility have on 
the activation of pro-inflammatory cytokines, specifically tumor necrosis factor-a (TNF-
a) and interleukin-6 (IL-6).7,177-181 Inflammation is characterized by an interaction 
between pro-inflammatory cytokines and anti-inflammatory cytokines. Usually anti-
inflammatory cytokines counteract the toxic effects of pro-inflammatory cytokines; 
however, patients with HF182 as well as negative emotions176 have increased levels of 
pro-inflammatory cytokines. Cytokines activate macrophages and increase the growth of 
fibroblasts and collagen leading to myocardial wall fibrosis and wall-motion 
abnormalities resulting in myocardial remodeling and decreased left ventricular ejection 
fraction.114,183 Elevated levels of TNF-a is associated with worsening and more severe 
HF.184 In concert with other neurohumoral processes, proinflammatory cytokines 
suppress cardiac contractility,185 increase apoptosis,185 increase HF symptoms,182 
facilitate myocardial remodeling,186 and result in adverse health outcomes in patients with 
HF.187 In addition, IL-6 is implicated in the development of future HF.188  
Heart failure is usually the end result of cardiovascular disease. Negative 
emotional states increase the levels of circulating proinflammatory cytokines which may 
be involved in the pathogenesis of atherosclerosis and resulting cardiovascular 
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disease.18,189 Damage to the endothelium lining in the coronary vessels stimulates the 
release of proinflammatory cytokines such as interleukin (IL)-1, IL-6, and tissue necrosis 
factor alpha (TNF-α). The release of cytokines encourage adhesion of inflammatory cells 
to the endothelium which then further activate more cytokine and growth factor 
release.190 Intimal smooth muscle cells then proliferate and accelerate the atherosclerotic 
process. In a study of healthy adult volunteers, Gianaros7 found those individuals exposed 
to situations generating negative emotions had the greatest levels of IL-6 as well as 
greater carotid artery intima-media thickness and inter-adventitial diameter, indicating 
preclinical atherosclerosis. The same inflammatory process is also implicated in the 
development of vascular depression due to the endothelial damage to the cerebral 
arteries.18 
Change in platelet receptors and function. Studies suggest negative emotional 
states produce changes in the clotting process including increased platelet aggregation,191 
vasoconstriction, and subsequent plaque rupture.192,193 Increased SNS activation provides 
a pathway for thrombogenesis.194 Findings of studies examining the role of negative 
emotions and platelet reactivity have been inconsistent. Depression and platelet reactivity 
have been studied to a greater extent than anxiety and hostility.195 In a study191 of 153 
individuals without a history of cardiovascular disease (108 were depressed, 45 were 
controls), investigators found that depression was significantly associated with platelet 
activation and when depression resolved, platelet activation was reduced. However, in a 
study196 of 83 stable cardiac patients, investigators found anxiety was a better predictor of 
platelet reactivity than depression. Further, in a study197 of hypertensive patients without 
a history of cardiovascular disease, researchers found that hostility was significantly 
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associated with platelet reactivity and did not diminish when controlling for other risk 
factors. While the role of negative emotions and platelet reactivity may not be fully 
understood, negative emotions have been shown to be predictive of poor health outcomes 
such as acute myocardial infarction198,199 and subsequent cardiovascular mortality. 
Cardiac remodeling. Cardiac remodeling occurs as a compensatory mechanism 
for a failing left ventricle which results in changes in the size, shape, and function of the 
myocardium.200 The process of cardiac remodeling and subsequent HF occurs as a result 
of damage or injury to the heart and are influenced by autonomic dysregulation201,202 and 
neurohumoral activation203 as well as activation the HPA axis and RAAS.200 While these 
compensatory changes are in response to falling cardiac output in the face of increased 
cardiac workload, these changes are also responsible for deterioration in cardiac function 
and physiologic cardiac remodeling and progression of HF.200,204 Elevated circulating 
levels of angiotensin II, aldosterone, NE, E, and proinflammatory cytokines result in 
dilation of the left ventricle and increased inotropic and chronitropic effects on the 
myocardium to adapt to increased volume.204 After the ventricle wall is chronically 
stretched, myocytes decrease in number (apoptosis)205,206 and become elongated and 
hypertrophied as an adaptive process. The LV will hypertrophy, and fibroblasts will 
proliferate207 and increase collagen synthesis208 which leads to fibrosis209 and further 
hypertrophy of the LV. As compensatory changes continue, the heart will actually change 
shape, becoming less elliptical and more spherical.200,210,211  
Symptoms of anxiety, depression, and hostility complicate and hasten the 
remodeling process of the myocardium in patients with HF as negative emotions are 
associated with further increases in autonomic dysregulation, neurohumoral and immune 
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system changes, and activation of the HPA axis and RAAS.35 The heart must work harder 
to overcome increased hemodynamic load and changes resulting from physiological 
hyperreactivity of systems that are activated to maintain cardiac output. Wall-motion 
abnormalities and decreased left ventricular ejection fraction from impaired ventricular 
function are associated with negative emotions.212,213 While not all patients with HF 
experience symptoms of anxiety, depression, and hostility, these negative emotions have 
been strongly implicated in hastening and progression of HF by exacerbating common 
biological compensatory processes18 and contribute to increased mortality in this 
population.32 
Summary of potential physiological hyperreactivity. The potential physiological 
hyperreactivity is a plausible pathway through which negative emotions may confer 
increased risk of poor health outcomes in patients with HF. Heart failure is a progressive 
adaptation and remodeling due to injury and cardiac demand. Negative emotions elicit 
further autonomic system dysregulation, neurohumoral changes, increased activation of 
the HPA axis, RAAS, and cytokine cascade, changes in platelet receptors and function, 
and remodeling of the myocardium resulting in hastening and progression of HF. Patients 
with HF who experience negative emotions may be at greater risk of disease progression 
and poor outcomes than those patients with HF who do not experience negative 
emotional states.35 
Potential behavioral pathways. In addition to the proposed physiological 
hyperreactivity pathway, another possible pathway linking symptoms of anxiety, 
depression, and hostility with poor health outcomes is the manner in which symptoms of 
anxiety, depression, and hostility can produce certain behaviors in patients with HF that 
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result in worse health outcomes. Patients with negative emotions often fail to adhere to 
medical treatment regimens such as medications, 26,27,113,214-217 continue or adopt risky 
lifestyles such as smoking or a sedentary lifestyle,116,217,218 and often do not utilize 
appropriate resources (e.g., cardiac rehabilitation, clinic appointments, counseling) that 
can assist them achieve better health outcomes.219-221  
Nonadherence. Negative emotions impact rehospitalization, P-HRQOL, and 
mortality of patients with HF due to their influence on patient adherence to treatment 
regimens. After discharge from the hospital for HF, approximately 23% to 28.9% of 
Medicare beneficiaries are rehospitalized within 30 days.222-224 O’Connor and colleagues 
found that rehospitalization rates for HF patients increased to 57.9% after 60 days from 
discharge after initial hospitalization.225 However, as many as 44% to 82% of patients 
with HF are readmitted to a hospital within 90 days to one year following hospitalization 
for decompensated HF.226,227 One of the key factors in prevention of hospital 
readmissions among patients with HF is poor self-care, which includes adherence to 
treatment regimens and monitoring of symptoms.  
Nonadherence to treatment regimens is associated with poor health outcomes and 
worse HF symptoms as well as increased rates of emergency department visits and 
rehospitalizations.228-230 It is estimated that one-half to two-thirds of HF related 
hospitalizations could be prevented by better patient adherence.215,216,231 The average rate 
of nonadherence in HF patients is approximately 40% to 60%; however, rates of 
adherence have been reported in the literature ranging from 10% to 98% depending on 
the methods used to measure adherence.232 
Evidence suggests that negative emotions may be an important contributor to 
22 
nonadherence among patients with HF.233 In the cardiovascular population, patients with 
depression are more likely to have poor adherence with prescribed medications, diet, and 
exercise regimens.234,235 Tang et al.27 found that patients with HF who were depressed 
were 2.3 times more likely to report nonadherence to prescribed medications than those 
patients who were not depressed. Farrell and colleagues29 examined whether depression, 
hostility, social support, and personality traits known to influence medication adherence 
would be predictive of patient adherence to HF medications. These authors reported that 
both depression and hostility were predictive of medication adherence among patients 
with HF. In addition, DeJong and colleagues26 found anxiety independently predicted 
medication adherence among 147 patients with HF and suggested anxiety mediated the 
relationship between nonadherence and event-free survival. 
Depressive symptoms such as fatigue, lack of motivation, problems with 
concentration, social withdrawal, and feelings of worthlessness may hinder the ability of 
patients to adequately follow prescribed treatment plans.236 Anxiety may hinder 
adherence to treatment regimens due to the need for lifestyle changes which may 
overwhelm their coping ability as anxious individuals have fewer coping responses 
needed to deal with change.17,237 In a study of patients hospitalized for a myocardial 
infarction, Moser et al.238 found patients with high levels of anxiety had feelings of a low 
sense of control leading to feelings of powerlessness. Cynicism and a basic mistrust of 
others are characteristic of hostile individuals who are more likely to have poor 
adherence with medications238 as well as diet and exercise.217,240  
Negative emotions also contribute to impairments in attention, memory, and 
executive function such as problem solving.241 Rosenberg et al.242 reported depression 
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predicted impairment in cognitive functioning including episodic, immediate, and 
delayed memory as well as impaired psychomotor speed and executive functioning. In a 
study of patients with HF and depression, Garcia et al. reported depression was found to 
be predictive of cognitive impairments to executive function, memory, language, and 
motor function even after controlling for sex, cardiac fitness, and presence of a 
comorbidity such as hypertension.243 An impairment in memory, attention, or decision-
making, often seen in negative emotional states, can interfere with many aspects of daily 
life and the ability to care for oneself.244 Depressed patients have more errors of attention 
when compared to nondepressed patients as well as performance deficits in working 
memory and attention that worsen with severity of illness.245,246 Depressive thoughts (e.g. 
intrusive thoughts) limit working memory and impairs a patient’s ability to learn and 
retain new information.247 Subsequently, negative emotional states decrease the speed 
with which patients with HF can learn, synthesize, and recall information about their 
condition and their prescribed medical regimen.  
Several meta-analyses describe the complex relationships between negative 
emotions and cognitive performance. In a meta-analysis of the effects of depression and 
anxiety on memory performance, Kizilbash et al.248 found comorbid depression and 
anxiety had an adverse effect on immediate recall and amount of acquisition of new 
knowledge as well as on the ability of patients to retrieve the newly learned information. 
In addition, Zaninotto and colleagues249 demonstrated that patients with negative 
emotional states (e.g. melancholic) not only had worse cognitive performance in 
attention, working memory, and visual learning, but also in reasoning and problem-
solving than those patients without symptoms. While hostility is often viewed as a 
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relatively stable personality trait and shown to be predictive of CAD250,251 and worsening 
of HF,217,252 it is also shown to be independently associated with cognitive 
impairment.253,254 Studies suggest hostility may influence cognition through exaggerated 
cardiovascular or neuroendrocrine responses255 as well as a vulnerability to experience 
increased levels of stress than non-hostile individuals,256 both of which impair memory 
and recall.253 These studies suggest that negative emotions contribute to cognitive 
dysfunction in patients with HF resulting in problems with learning appropriate self-care 
about the disease. Heart failure self-care requires understanding of a relatively complex 
medical regimen, being able to detect significant changes in symptoms, and evaluating 
changes in symptoms and needed actions to prevent worsening of symptoms. 
In a meta-analysis of studies on brain changes in clinically depressed patients 
without HF, Palmer and colleagues257 reported there were consistent changes in the 
brains and affecting integrated pathways linking select cortical, subcortical and limbic 
sites. The meta-analyses reported that demand of the task would determine what network 
would be activated and depression would dampen the efficiency of functions of the 
network.257 This would suggest that clinically depressed patients would need to apply 
greater conscious effort in completing the same task than nondepressed indviduals.257 The 
cognitive impairments found in the changes of the brains of depressed patients interfere 
with learning and understanding treatment regimens, particularly remembering to take 
medications, maintaining follow-up appointments and check-ups, as well as continuing 
appropriate diet and exercise. Therefore, adherence to medical regimens would be 
especially difficult for patients with HF whose medical regimen is very complex.  
In addition, symptom awareness and subsequent management of those symptoms 
 
 
25 
 
 
also influence adherence to the recommended HF regimen and optimal self-care. 
Symptom awareness is influenced by cognitive appraisal of a patient’s perception of that 
threat. Smith and Lazarus258 proposed six domains of cognitive appraisal: (a) 
motivational relevance; (b) motivational congruence related to one’s goals; (c) 
accountability related to placement of blame (self versus others); (d) problem solving 
related to coping potential; (e) emotion-focused potential (how an individual perceives 
coping ability should the situation not change); and (f) perception of how likely the 
situation is to change. Negative emotional states, as with symptoms of anxiety, 
depression, and hostility, are associated with a dysfunctional cognitive appraisal.52,64,259 
260 Often individuals with negative emotions interpret information in a negative manner 
and have problems in cognitive control in the processing of negative material as they 
have an enhanced memory for negative material.261 
Individuals with symptoms of anxiety, depression, and hostility all appraise 
situations according to motivational relevance and motivational congruence related to 
their goals.193 However, individuals with specific negative emotional states may view 
events and respond differently to events due to dysfunctional cognitive appraisal. 
Individuals experiencing symptoms of sadness and guilt, as in depression, appraise 
situations in a way that results in low expectations for their abilities to effect change. 
193,262 Anxious individuals have low or uncertain emotional focused potential within the 
cognitive appraisal domains which influences how they view their ability to handle a 
situation psychologically and often use avoidant coping.258 Hostile individuals often have 
attributional bias and are not motivated to change as they do not see their behavior as the 
cause of any problem.259 Subsequently, faulty cognitive appraisals associated with 
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negative emotional states influence an individual’s ability to perceive the situation 
correctly as well as their subsequent behavioral and coping responses.258  
Risky behaviors. Emotions may affect behaviors or adherence to medical 
treatment regimens124 that may in turn influence the health outcomes of patients with HF. 
Patients with HF often have bothersome physical symptoms as well negative emotional 
states and often adopt risky behaviors to alleviate or cope with these symptoms. Anxious 
and depressed individuals are more likely to eat unhealthy diets, gain weight, adopt 
sedentary lifestyles, and fail to quit smoking.17,263,264,265 In studies of patients having an 
acute myocardial infarction, those individuals with higher anxiety and depressive 
symptoms were more likely to resist smoking cessation17,266 and were more likely to be 
heavy smokers.267 Wong et al.217 reported hostility was significantly associated with poor 
health behaviors, physical inactivity, and smoking. In addition negative emotions were 
associated with higher intake of alcohol in an attempt to cope; however, intake of alcohol 
was also associated with greater anxiety, depressive, and hostility symptoms.268,269 
Clearly, negative states put patients with HF at greater risk for adopting or maintaining 
unhealthy lifestyles that may lead to exacerbations of HF. 
Limited use of appropriate healthcare resources. Negative emotions hinder a 
patient’s ability utilize appropriate resources to maintain optimal health. Coping style is 
viewed as an important predictor of the course of HF progression and health outcomes.16 
Patients with higher levels of anxiety and depressive symptoms frequently utilize 
avoidant coping18,270 which includes denial, behavior disengagement, self-blame and 
substance abuse.271 Patients with higher levels of hostility have poorer physical health, a 
pessimistic attitude, unrealistic expectations of self and others, a desire to avoid 
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difficulties, and are more likely to utilize escape-avoidance, and confrontive coping 
styles.268 In addition, hostile individuals often have attributional bias, which influences 
their ability to take responsibility for their actions. Negative emotional states may 
produce behaviors that are not proactive resulting in behavioral disengagement that can 
manifest itself by missed clinic appointments, lack of participation in cardiac 
rehabilitation, and lack of utilization of medical and counseling services. Behavioral 
disengagement is viewed as a self-destructive behavior that can significantly affect 
health. Murburg and Bru272 reported behavioral disengagement was a significant 
predictor of mortality risk among patients with HF who were followed for a 2-year 
period. Avoidance coping is maladaptive and predisposes a patient to ignore medical 
advice and symptoms that may signify the need to seek medical attention for early 
intervention.273 Conversely, adaptive coping promotes active engagement to encourage 
patients to monitor symptoms, seek medical attention, and adequately manage HF 
symptoms and progression of the disease.274 
Summary of potential behavioral pathways. The potential behavioral pathway of 
negative emotions in patients with HF is a plausible mechanism for poor health-related 
outcomes such as disease progression, poor quality of life (QOL), increased 
hospitalizations, and mortality.16-18 The behavioral pathway may also influence the 
physiological pathway through nonadherence to medical regimens, adoption of 
maladaptive or risky behaviors (e.g. smoking, weight gain, eating a diet high in fat and 
sodium, and excess alcohol intake), and limited use of appropriate resources. 
Nonadherence to medical regimens is common in patients with negative mood states. The 
association between the physiological and behavioral pathway is bi-directional as 
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illustrated in Figure 1.1. The physiological pathway provides for a mechanism that may 
adversely affect HF progression, impair cognition, and the ability of patients to adhere to 
medical regimens.117 Conversely, the behavioral pathway provides a mechanism that 
influences the physiological response to negative emotions through inadequate self-care 
behaviors such as nonadherence, adoption of risky behaviors, and failure to utilize 
appropriate health resources to prevent exacerbations of HF symptoms. 
Aims of Dissertation 
Most of the research surrounding negative emotional states and their associations 
with health outcomes has traditionally occurred within the literature related to the 
development of coronary artery disease (CAD), risk of myocardial infarction, or 
development and progression of cardiovascular disease. However, in the last several 
decades there has been an increase in interest related to exploration of negative emotional 
states and how they influence the health-related outcomes in HF. The interaction of 
negative emotional states with other aspects of the lives of patients with HF impact the 
progression of HF, mortality, readmission, as well as physical HRQOL.24,275 Negative 
emotions in patients with HF are associated with increased cardiovascular risk and worse 
health-related outcomes.9-12,16,17,20,21,23-26,34,36,37,49,96,107,112,114,116,141,198,217,251,252,264,276  
This dissertation will fill some of the gaps in the literature more fully through 
increasing our understanding of how symptoms of anxiety, depression, and hostility 
influence health outcomes of patients with HF. Symptoms of depression and anxiety16 
have been studied more often than hostility in patients with HF. Part of the issue may be 
that most hostility measures are long and cumbersome, creating an undue burden on 
patients. The BSI Hostility Subscale60 is a short self-report measure of hostility 
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commonly used in patients with HF; however, the psychometric properties have not been 
examined in this patient population.  
In exploring the influence of negative emotions on poor health outcomes, my 
dissertation proposes two potential pathways moderating the relationships between 
negative emotional states and poor P-HRQOL, hospital readmissions, and mortality. 
Potential pathways proposed are biological hyperreactivity and behavioral pathways, 
similar to what has appeared previously in the literature.16,17,124 In addition to examining 
the relationship of negative emotions on future health-related outcomes, the study 
described in Chapter 2 of this dissertation also examines the influence of negative 
emotions on self-care. Self-care has been identified as the single most important variable 
in preventing or limiting exacerbations of HF symptoms.277  
Many of the studies in the literature examining the relationships between negative 
mood states and poor health outcomes have utilized cross-sectional data measuring 
negative emotional states and their relationship to health-related outcomes at one point in 
time. Of the longitudinal studies examining trajectories of negative emotional states at 
different points in time, pre-set cut-points on negative emotional states were used to 
determine how patients would be grouped.24 While this method of analysis provides 
valuable information on the effects of negative emotional states and health outcomes, 
studies utilizing this method cannot fully describe the extent to which negative mood 
states may change and fluctuate over the course of time and how these patterns of change 
influence the health of patients with HF. The study in Chapter 4 is the first to utilize 
latent growth modeling to determine naturally occurring trajectories of anxiety and 
depressive symptoms without pre-determined groupings and examine their relationship to 
 
 
30 
 
 
cardiac related events and P-HRQOL.  
Therefore, the purpose of this dissertation was to examine how symptoms of 
anxiety, depression, and hostility influence health outcomes of patients with HF as well 
as describe how these psychological variables change over time, and whether different 
trajectories of these variables are associated with different health outcomes. Thus, the 
primary aims of this dissertation are threefold: 1) provide evidence of the psychometric 
properties of the BSI Hostility Subscale as a valid and reliable instrument to assess the 
hostility symptoms of patients with HF; 2) determine whether symptoms of anxiety, 
depression, and hostility at baseline predict better self-reported self-care at one-year 
among patients with HF; and 3) describe trajectories of anxiety and depressive symptoms 
among patients with HF across three points in time (baseline, 3 months and 12 months) 
and explore whether these symptom trajectories predict one-year cardiac event-free 
survival and P-HRQOL.  
Summary of Subsequent Chapters 
 Chapter 2 is an analysis of the psychometric properties of the BSI Hostility 
Subscale. The BSI Hostility Subscale is widely used to assess symptoms of hostility in 
many populations,56,60,278 including patients with HF.105 However, reliability and validity 
of the subscale have not been evaluated in this population. Cross-sectional data of a 
subset of 345 patients enrolled in a larger longitudinal study of 1,136 patients were used 
for this analysis. The primary aims of this study were to (1) explore the dimensionality of 
the subscale in patients with HF; (2) assess the internal consistency of the subscale; and 
(3) evaluate the construct validity of this subscale. The hypotheses were that levels of 
hostility would be positively associated with measures of anxiety and depressive 
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symptoms and negatively associated with perceived social support.  
In Chapter 3 I present findings from a secondary analysis of data in which I 
examined whether anxiety, depressive symptoms, and hostility were predictive of self-
care and P-HRQOL at 12 months in patients with HF. The conceptual framework for the 
relationship of negative emotions and self-care is outlined in Figure 1.2. Data analyzed in 
this study were collected as part of larger longitudinal studies of patients. A subset of 214 
patients with complete data on the variables of interest was used in this analysis.  
In Chapter 4 I present results from a study I conducted to identify trajectories of 
depressive and anxiety symptoms in patients with HF over 12 months and determine 
whether changes in these symptoms were predictive of subsequent P-HRQOL and event-
free survival at one year. Little is known about trajectories of depressive and anxiety 
symptoms in patients with HF and how these influence health outcomes over time. This 
study was a secondary data analysis of data collected as part of a larger longitudinal study 
of patients enrolled in the Heart Failure Quality of Life Trialists Collaborative 
contributed to by investigators at eight different sites in the United States. The design, 
procedures, and results of the primary studies have been previously reported.276,279 The 
study sample consisted of a subset of 597 patients with HF enrolled in the larger 
longitudinal studies. Baseline, 3-month, and 12-month data on the variables of interest 
were used in the analysis. Latent growth mixture modeling was used to identify distinct 
trajectories of change in depressive and anxiety symptoms. 
In Chapter 5 I present an integrated summary, discussion, and conclusion. 
Included in this chapter is a discussion of the implications from these studies as well as 
recommendation for future research to advance our understanding of the relationship of 
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symptoms of anxiety, depression, and hostility and their influence on self-care and 
health-related outcomes.  
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Figure 1.1 Overarching Framework for Conceptualizing the Biobehavioral Influences of 
Anxiety, Depressive, and Hostility Symptoms on Health Care Outcomes in Patients with 
Heart Failure 
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Figure 1.2 Conceptual Framework of Relationship of Anxiety, Depressive, and Hostility 
Symptoms to Self-Care and Subsequent Health Outcomes 
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Chapter Two: Psychometric Properties of the Brief Symptom Inventory  
Hostility Subscale in Patients with Heart Failure 
 
Introduction 
 The purpose of the study was to investigate the psychometric properties of the 
Hostility Subscale of the Brief Symptom Inventory (BSI) in adult patients diagnosed with 
heart failure (HF). More than 5.7 million Americans suffer from HF which is associated 
with high rates of morbidity and mortality, poor health outcomes, and repeated 
hospitalizations.1 Heart failure is a progressive and deteriorating condition characterized 
by multiple distressing physical and psychological symptoms. Subsequently, patients 
with HF experience greater levels of psychological distress and hostility when compared 
to their healthy counterparts or those with other cardiac conditions.2 Hostility is an 
independent risk factor for poor health outcomes and is associated with increased risk for 
repeat hospitalizations for cardiovascular events such as HF.3 Consequently, reliable and 
valid instruments that measure hostility in patients with HF are needed to adequately 
understand the relationship between hostility and HF and how hostility influences health 
outcomes.  
Background and Conceptual Framework 
The concept of hostility typically is defined as a negative attitude toward others 
accompanied by mistrust, cynicism, aggressive behaviors, and feelings of anger.4,5 
Although hostility has been associated with the development of cardiovascular disease 
(CVD) for many years, the results of existing research are inconsistent related to the 
mechanisms by which hostility influences CVD or other cardiovascular related events.6,7,8 
One mechanism may be that hostility exerts a toxic effect on the cardiovascular system 
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through a physiological pathway which activates potentially harmful neural, endocrine, 
and inflammatory responses.9,10 Another mechanism may be that hostility promotes poor 
health and self-care behaviors such as physical inactivity and nonadherence with 
medications.8,11 The inconsistencies may be because of  the multidimensional nature of 
hostility which has been challenging to define and difficult to capture,12 because hostility 
includes complex emotional, cognitive, and behavioral processes.13,14 In addition, most 
studies investigating the associations of hostility with CVD and HF used diverse hostility 
measures that include not only self-report measures but also structured interviews.4 
Although the BSI Hostility Subscale is commonly used with many populations, its use in 
patients with HF is limited.  
Despite a large body of research investigating the role of hostility in developing 
CVD or its influence on the progression of heart disease, there is limited research on the 
relationship of hostility to health outcomes in patients with HF. More importantly, there 
is even less research available about interventions to decrease levels of hostility with the 
goal of improving health outcomes. Some cardiac rehabilitation programs address 
negative emotional states such as hostility to improve risk factor profiles for recurrent 
events, increase adherence to medication regimens, and support lifestyle changes to 
improve overall quality of life.15 However, to understand hostility and its influence on 
outcomes in patients with cardiac problems and HF, clinicians need a brief, 
psychometrically sound measure of hostility that does not increase patient burden—one 
that can be easily scored and interpreted by clinicians. 
The specific aims of this study were to: (1) assess the internal consistency and 
reliability of the BSI Hostility Subscale; (2) explore the dimensionality of the BSI 
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Anxiety, Depression, and Hostility Subscales through principal component and 
exploratory factor analyses to determine whether the Hostility Subscale is a distinct 
dimension of the BSI in a sample of patients with HF; and (3) evaluate the construct 
validity of the BSI Hostility Subscale by testing the following hypotheses:  
H1: The higher the Hostility Subscale score, the greater the levels of depression 
measured by the Patient Health Questionnaire-9 (PHQ-9) and the BSI Depression 
Subscale.  
H2: The higher the Hostility Subscale score, the greater the BSI Anxiety Subscale 
score. 
H3: Greater hostility will be associated with lower perceived social support as 
measured by the Multidimensional Scale of Perceived Social Support (MSPSS).  
Construct validity is an important part of psychometric testing concerning the 
validity of an instrument and includes both convergent and discriminant validity. Our 
hypotheses reflect how the BSI Hostility Subscale should or should not correlate with 
other measures. 
Methods 
Research Design. The cross-sectional data for this secondary data analysis were 
collected as part of a larger longitudinal study of 1,136 patients who participated in nine 
clinical trials at eight sites representing the Midwest, Southwest, Southeast, Northwest, 
and Northeast regions of the United States.16,17   
Sample. A subset of 345 patients with complete data on the variables of interest 
comprised the sample for this study. Patients who did not have complete data were 
excluded.  There were no sociodemographic differences between those who did and did 
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not have complete data.  Incomplete data was the result of some sites not collecting on 
the variables of interest. Eligibility criteria were similar at all sites: (1) documented 
diagnosis of HF associated with preserved or nonpreserved left-ventricular systolic 
function, and (2) ability to read and write English. Patients were excluded if they had an 
acute myocardial infarction (MI), unstable angina, cognitive impairment, or severe 
psychiatric problems requiring acute treatment. In addition, patients discharged to an 
extended care or skilled nursing facility and those who were homeless were excluded.  
Measures.  
Hostility. Hostility was defined as an emotional, cognitive, and behavioral 
dimension that involves negative beliefs and attitudes about people and human nature.18 
Although it is associated with anger and aggression, hostility is characterized by a 
negative cognitive and behavioral style that affects an individual’s expectations, 
perceptions, and responses to others. Hostility was measured using the Hostility Subscale 
of the BSI. The Hostility Subscale consists of five items from the original BSI, a 53-item 
self-report inventory describing nine primary dimensions: Somatization, Obsessive-
Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, 
Paranoid Ideation, and Psychoticism.19 Patients respond to the stem, “…circle the number 
to the right that best describes how much the problem has distressed or bothered you 
recently, including today.” Each item is rated on a 5-point scale of distress ranging from 
0 (not at all) to 4 (extremely). A total score is calculated by summing the values for each 
item and dividing by 5 resulting in scores ranging from 0 to 4. The threshold norm for 
adult non-patients is .35 ± .42.19  
 Items for the Hostility Subscale of the BSI were selected based on a factor 
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analysis of the Symptom Checklist-90-Revised (SCL-90-R); those items with the 
strongest loadings on the hostility dimension were selected to form this subscale.20 In a 
sample of 1002 psychiatric outpatients, Derogatis and Melisaratos19 confirmed the nine 
primary symptom dimensions of the BSI through principal component analysis which 
included the Hostility Subscale. The subscale has good internal consistency. Cronbach’s 
alpha was .78 in a study of 1,002 adult psychiatric outpatients, and in a sample of 60 non-
patients who were tested across a 2-week period, the test-retest reliability coefficient was 
.81.19 Several studies support the internal consistency of the BSI Hostility Subscale in 
samples of patients with HF with Cronbach’s alpha of .80 and .79.21,22  
Depressive symptoms. Depression was defined as a negative affective state 
associated with a range of depressive symptoms related to dysphoric mood and affect that 
influence an individual’s view of self, the world, and the future.7 Depressive symptoms 
were measured using the PHQ-9 and BSI Depression Subscale.  
Patient Health Questionnaire-9. The PHQ-923 is a self-administered measure of 
the presence and severity of depressive symptoms. It was developed from the full PHQ 
according to criteria for clinical depression outlined in the Diagnostic and Statistical 
Manual of Mental Disorders (4th ed., DSM-IV) and includes emotion and somatic 
dimensions of depression.24 The PHQ-9 is composed of nine Likert scale items. Patients 
are asked to rate how often in the past 2 weeks they experienced each symptom on a scale 
of 0 (not at all) to 3 (nearly every day); therefore, possible scores range from 0 to 27. 
Higher scores reflect higher levels of distress and depressive symptoms according to the 
following categories: 0-4 (minimal depression); 5-9 (mild depression); 10-14 (moderate 
depression); 15-19 (moderately severe depression), and 20-27 (severe depression). The 
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PHQ-9 had excellent reliability in samples of 3,000 obstetric-gynecologic patients23 and 
3,000 adult patients in a primary care setting.25 with Cronbach’s alphas of .89 and .86, 
respectively. Cronbach’s alpha was .83 in two different samples of patients with HF26,27 
which supports the reliability of the PHQ-9 in this population. In the present sample, the 
Cronbach’s alpha was .85. 
Brief Symptom Inventory Depression Subscale. The BSI Depression Subscale is 
composed of six items selected based on factor analysis of the SCL-90-R.28,29 Items in the 
scale represent a range of symptoms of clinical depression such as dysphoric mood and 
affect characterized by a lack of motivation and loss of interest in life. Each item is 
scored from 0 (not at all) to 4 (extremely). A score is derived by summing the item values 
and dividing by six. Scores on the subscale range from 0 to 4. Higher scores indicate 
higher levels of distress and severity of symptoms of depression. The mean score in a 
sample of 719 healthy non-patients was reported by Derogatis and Melisaratos19 as .28 ± 
.46. The Depression Subscale has good internal consistency; Cronbach’s alpha was .85 in 
a sample of 60 non-patients19 and was stable over a 2-week period of time with a test-
retest reliability coefficient of .84. The BSI Depression Subscale had good internal 
consistency in two studies of patients with HF with Cronbach’s alphas of .78 and .82.30,31 
In our sample, Cronbach’s alpha was .88. 
Anxiety. Anxiety was defined as a state of uneasiness, nervousness, and 
restlessness. It was assessed with the six-item BSI Anxiety Subscale, derived by 
Derogatis20 via factor analysis of the SCL-R-90. This subscale includes statements about 
symptoms of anxiety such as nervousness, tension, feelings of terror, apprehension, and 
spells of terror or panic. The items within the subscale are scored from 0 (not at all) to 4 
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(extremely). The score is obtained by summing the values of each item and dividing by 
six; scores range from 0 to 4. A mean score of .35 ± .45 was reported in a sample of 719 
healthy non-patients.19 Cronbach’s alpha in this healthy sample was .81. In addition, the 
BSI Anxiety Subscale was stable across a 2-week time period with a test-retest 
coefficient of .79 in a sample of 60 non-patients.19 The BSI Anxiety Subscale had good 
internal consistency in several samples of patients with HF27,31,32 with Cronbach’s alphas 
of .85, .83, and .84, respectively. In the study, the Cronbach’s alpha for the Anxiety 
Subscale was .82. 
Perceived social support. Perceived social support was defined as a subjective 
feeling of support, help, and comfort from family, friends, and significant others. It was 
assessed using the self-report MSPSS.33 The MSPSS consists of 12 items addressing 
social support from three groups: family, friends, and significant other. Four items are 
asked for each group and are rated on a 7-point Likert scale ranging from 1 (very strongly 
disagree) to 7 (very strongly agree). Items are summed for a total score and subscale 
scores for Family, Friends, and Significant Other. Total scores range from 12 to 84; 
subscale scores range from 4 to 28. Higher scores indicate greater levels of perceived 
social support.33 The authors reported a Cronbach’s alpha of .88 in a sample of 275 
undergraduate students. Dahlem et al.34 and Riegel et al22 reported Cronbach’s alphas of 
.90 and .95, respectively, in samples of patients with HF. Cronbach’s alpha in the present 
sample was .88. 
Data collection. Institutional review board approval was obtained at each site. 
Specially trained nurse researchers explained the purpose and procedures to each 
participant in the study. All patients gave signed, informed consent. Data were collected 
 
 
42 
 
 
through the use of self-administered questionnaires and structured patient interviews 
conducted by trained cardiovascular nurses. Nurses ascertained the weight and height of 
each participant and interviewed patients in order to complete sociodemographic data. 
Subsequently, participants were given a packet of self-administered questionnaires with 
instructions regarding how to complete each questionnaire. The nurse researcher 
examined all questionnaires to make sure participants did not inadvertently leave any 
items unanswered; however, participants were free to leave items unanswered. 
Data analysis. Statistical analyses were performed using the SPSS for Windows 
(version 18.0, SPSS, Inc., Chicago, IL). Descriptive statistics were computed for 
sociodemographic and clinical data as well as the BSI and its subscales, the PHQ-9, and 
the MSPSS. Potential differences in proportions by gender of the participant were tested 
by using 2 for categorical variables; differences in means of continuous variables by 
gender were evaluated using the independent samples t test. Bivariate relationships were 
evaluated using the Pearson product moment correlation coefficient for continuous 
variables; the Spearman rank order correlation was used for ordinal data. After ensuring 
there were no violations of the assumptions of normality, linearity, and homoscedasticity, 
the internal consistency reliabilities of the BSI Hostility and Anxiety Subscales were 
assessed using Cronbach’s alpha. Coefficients greater than .70 were deemed to represent 
good internal consistency. The 17 items of the three BSI subscales were subjected to 
PCA followed by exploratory factor analysis (EFA).  
Results 
Characteristics of the patients with HF are shown in Tables 2.1 and 2.2. Age was 
similar for both males and females (61  12 years and 59  12 years, respectively). There 
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was no significant difference in proportions for NYHA classification by sex of the 
patient. Males and females did not differ on mean scores on the BSI Hostility, 
Depression, and Anxiety Subscales. However, participants’ scores on the BSI Hostility, 
Depression, and Anxiety Subscales were elevated relative to published norms for adult 
nonpatients,28 reflecting greater hostility, depression, and anxiety symptoms for the 
patients with HF in our study. 
Reliability. The Cronbach’s alpha for the Hostility Subscale was .77, indicating 
good internal consistency for a subscale composed of only five items. Inter-item 
correlations between .30 and .80 were considered acceptable. Items with coefficients of 
.80 or greater indicate possible item redundancy.35 The inter-item correlation coefficients 
for the BSI Hostility Subscale ranged from .30 to .78. 
Dimensionality. Prior to performing the PCA, we determined the data were 
suitable for analysis through inspection of the inter-item correlation matrix of the BSI 
which revealed numerous coefficients of .30 and above as recommended by Kaiser.36,37 
In addition, the Kaiser-Meyer-Olkin value was .91, exceeding the value of .6 or above as 
recommended by Kaiser.36,37 The Bartlett’s test of sphericity38 was also significant (p < 
.0001).  
Principal component analysis revealed two eigenvalues exceeding one. Inspection 
of the scree plot also supported a two-dimensional structure. Varimax rotation of the two 
factors using exploratory factor analysis yielded: Factor I-- Dysphoria and Factor II--
Hostility. The BSI Hostility Subscale items loaded on both factors with moderate or 
strong loadings of .40 or greater; however, only three of the five items (Items 12, 13, and 
15) loaded on Factor II Hostility (see Table 2.3). The items that loaded on Factor II were 
 
 
44 
 
 
similar in content in that the items asked participants to rank how often they experienced 
urges or feelings of aggression. Although three of the five items loaded on Factor II, one 
item, “temper outbursts you could not control,” double loaded on both Factors I and II. 
When this item was removed from the subscale, Cronbach’s alpha for the BSI Hostility 
Subscale decreased from .77 to .70, and this item was retained in the subscale. Another 
item, “easily annoyed or irritated,” loaded on Factor I moderately strong. This item may 
describe a restless state more similar to those associated with anxiety.  
The items in the Anxiety Subscale of the BSI loaded exclusively on Factor l (see 
Table 2.3). Items on the Depression Subscale loaded strongly on Factor I (see Table 2.3) 
with the exception of Item 10, “thoughts of ending your life,” which loaded moderately 
strong on Factor II. Thus, the BSI Hostility Subscale was not clearly distinguished from 
the Anxiety and Depression Subscales in this sample. 
Construct Validity. Hypothesis testing. All hypotheses were supported thus 
providing evidence of construct validity of the BSI Hostility Subscale (Table 2.4). The 
BSI Hostility Subscale had strong, positive correlation with the BSI Depression Subscale 
and a moderate, positive correlation with the PHQ-9. Thus, patients with greater hostility 
had worse symptoms of depression. There was also a strong, positive correlation between 
the BSI Hostility Subscale and the BSI Anxiety Subscale. Patients who experienced more 
hostility also experienced more anxiety. There was a weak, negative correlation between 
the BSI Hostility Subscale and the MSPSS. Patients who perceived less social support 
reported greater hostility.  
Discussion 
Although studies exist on the psychometric properties of the complete nine 
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dimensions of the BSI, we found no studies that examined the reliability and validity of 
the BSI Hostility Subscale among patients with HF. The BSI and its various subscales 
have been used in numerous studies in patients with HF.30,32,39,40 One study examined the 
psychometric properties of the BSI Anxiety and Depression Subscales in this 
population;31 however, there were no prior studies of the reliability and validity of the 
BSI Hostility Subscale in patients with HF. The results of this study provide initial 
support for the psychometric soundness of the BSI Hostility Subscale as a measure of 
hostility in patients with HF. 
The BSI Hostility Subscale demonstrated satisfactory reliability and validity in 
patients with HF. The Hostility Subscale demonstrated good internal consistency. The 
hypotheses were supported, providing evidence of construct validity.  
The two-factor model reflected dimensions of dysphoria and hostility. Agitation 
and annoyance with others, accompanied by aggression and anger, are often cited as 
common emotional and behavioral components of hostility.41,42 Three items loaded on 
Factor II; one item asking about temper outbursts which cannot be controlled double 
loaded on both Factors I and II. This item covers a broad concept influenced by personal 
perception or may measure different aspects of one component, namely that of temper 
outbursts and personal control. This item may have double loaded because of the 
ambiguity in defining an outburst one cannot control; individuals who have frequent 
temper outbursts may not perceive themselves as out of control. However, rewording of 
this item may produce better discrimination. Perhaps asking about frequent temper 
outbursts, getting mad or upset, or arguing with others without asking about control 
would produce a less ambiguous item. In addition, one item loaded on Factor I, rather 
46 
than Factor II, representing the dysphoric symptoms of hostility (agitation, annoyance). 
This is not surprising, because anger, aggression, antagonistic behavior as well as 
annoyance, irritation, and cynicism, are all facets of hostility and hostility measures 
usually assess these very different components.41 This item may describe a restless state 
more similar to feelings associated with anxiety. Examination of the inter-item 
correlations demonstrated there was no redundancy among items of the BSI Hostility 
Subscale. 
In addition, items in the Anxiety and Depression Subscales of the BSI loaded 
almost exclusively on Factor I with the exception of one item on the Depression Subscale 
about ending one’s life which loaded on Factor II. This may be because ending one’s life 
may be viewed as an act of hostility or aggression against oneself as suicidal acts have 
been correlated with self-reported hostility.43 Lemogne et al.44 found cognitive hostility 
was predictive of suicide independent of baseline depressive mood in a cohort study of 
14,752 non-patients over a mean follow-up of 15.7 years. 
Therefore, in this sample of patients with HF, the Hostility, Anxiety, and 
Depression Subscales of the BSI had two, not three, dimensions as proposed by 
Derogatis.28  
The results of our study supported the hypothesis that the BSI Hostility Subscale 
was associated with measures of depression, anxiety, and social support. There were 
strong positive correlations between the BSI Hostility Subscale and the Beck Depression 
Inventory-II, PHQ-9, and the BSI Depression and Anxiety Subscales. This is consistent 
with the findings of Moser et al.2 who demonstrated patients with HF had higher levels of 
hostility, depression, and anxiety compared to healthy elders. Lee and colleagues21 also 
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reported that hostility was positively associated with higher levels of depression and 
anxiety in patients with moderate to advanced HF. In addition, results from this study 
indicated there was a weak, negative correlation between the BSI Hostility Subscale and 
the MSPSS. Patients with HF who had higher levels of hostility had lower levels of 
perceived social support. Numerous studies support the negative correlation between 
hostility and social support.41,45 Other researchers also reported inverse relationships 
between hostility and perceived social support and sociability (appreciation of the 
company of others, cooperativeness, and responsiveness to social stimulation).46,47 
Blumenthal et al.48 found that patients undergoing coronary angiography who were also 
classified as Type A behavior pattern and reported better social support had lower levels 
of CAD as compared to their Type A counterparts with lower levels of social support. 
Social support, therefore, may confer a protective effect in the face of stress.49,50 Also, 
sociable individuals receive more support than unsociable individuals.51 
Limitations 
A limitation of this study is that the sample was not randomly selected; however, 
patients were recruited from multiple sites and the sample size was adequate for our 
analysis. Also worth noting is the influence of self-report bias. Patients in this study may 
have responded differently to the items in the BSI Hostility Subscale because of the 
influence of social desirability which may have more of an impact on the BSI Hostility 
Subscale than on other psychological measures such as depression and anxiety, as 
hostility is negatively viewed by society.41 In addition, most of the participants in this 
study consisted of white males which limits the generalizability of our findings to other 
groups such as women and minorities. 
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Conclusion and Implications 
Our study provides psychometric support for the BSI Hostility Subscale as a 
reliable and valid measure of hostility in patients with HF. In addition to the 
psychological symptoms of depression and anxiety, clinicians need to routinely assess 
hostility as part of follow-up visits throughout the treatment regimen to target 
interventions aimed at improving health. To this end, there is a distinct advantage of 
using a brief, five-item subscale to assess hostility levels in patients with HF without 
increasing respondent burden. Many hostility measures are longer and take more time to 
complete. Having a short, easy to use hostility measure that is reliable and valid allows 
clinicians to quickly assess a negative emotional state linked to poor health outcomes 
among patients with HF. We made recommendations for improvements in the BSI 
Hostility Subscale for future research. Although the link between hostility and heart 
disease is well established, more in-depth investigation of the relationships among 
hostility, HF, and poor health outcomes is needed using psychometrically sound 
measures of hostility.  
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Table 2.1. Demographic Characteristics of the Sample of Patients with Heart Failure  
(N = 345) 
 
Variable   n   % 
Sex   
Male 245 71.0 
Female 100 29.0 
Marital Status   
Single   43 12.5 
Married 181 52.5 
Divorced/Separated   63 18.3 
Widowed   46 13.3 
Co-habitate   12   3.5 
Race   
African-American   62 18.0 
Caucasian 279 80.9 
Hispanic/Latino/American-Indian/Alaskan Native/Mixed     4   1.2 
Educational Level   
Less than high school graduate   68 19.7 
High school graduate   82 23.8 
Business school or some college   82 23.7 
Associate Degree or Bachelor’s Degree   60 17.4 
Master’s Degree or higher   51 14.8 
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Table 2.1 (continued) 
Employment Status     
Employed full or part-time outside home   79 22.9 
Sick leave or disability   69 20.0 
Retired due to heart failure   83 24.1 
Retired not due to heart failure   87 25.2 
Other   25   7.2 
Smoking History   
Current Smoker   69 20.0 
Recent (stopped within 1 year)   22   6.0 
Former (stopped more than 1 year) 136 39.4 
Never smoked 118 34.2 
Drinking History   
Never  229 66.4 
1 or fewer alcoholic drinks per week   66 19.1 
2-7 drinks per week   37 10.7 
7 or more alcoholic drinks per week   11   3.2 
Exercise   
None   56 16.2 
Less than 30 minutes per week   49 14.2 
30-60 minutes per week   72 20.9 
1 to 3 hours per week   82 23.8 
More than 3 hours per week   86 24.9 
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Table 2.1 (continued) 
Variable   n   % 
Health Perception   
Excellent     3   0.9 
Very good   39 11.3 
Good 124 35.9 
Fair 138 40.0 
Poor   41 11.9 
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Table 2.2. Clinical Characteristics of the Sample of Patients with Heart Failure  
(N = 345) 
 
Categorical Variables n   % 
Etiology of Heart Failure   
Ischemic (heart disease) 172 79.9 
Idiopathic (unknown cause)   66 19.1 
Hypertension   33   9.6 
Valvular heart disease    2   0.6   
Alcoholic    3   0.9 
Postpartum    1   0.3 
Other   56 16.2 
NYHA Classification*   
I   29   8.4 
II 154 44.6 
III 132 38.3 
IV   29   8.4 
Missing     1   0.3 
Continuous Variables Mean ± SD 
Age   61.0 ± 12.0 
Left Ventricular Ejection Fraction   35.4 ± 3.9 
Body Mass Index   31.8 ± 7.6 
Months since Heart Failure diagnosis   78.0 ± 81.3 
Months since hospitalized for Heart Failure 211.0 ± 380.4 
*NYHA=New York Heart Association Classification 
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Table 2.3. Factor Pattern Matrix for Varimax Rotation of Two Factors for Items of the 
Brief Symptom Inventory (N = 345) 
 
Item number/Item/Subscale Factor 
    Ia    IIb 
  8.   Feeling fearful (Anxiety) .80 -.03 
  6.   Feeling blue (Depression) .80  .32 
  9.   Feeling hopelessness about the future (Depression) .80  .18 
  7.   Feeling no interest in things (Depression) .75  .19 
  5.   Feeling lonely (Depression) .73  .28 
1. Nervousness or shakiness inside (Anxiety) .72  .10 
11.   Feeling tense or keyed up (Anxiety) .68  .26 
  3.   Scared for no reason (Anxiety) .67  .05 
17.   Feelings of worthlessness (Depression) .65  .35 
2. Easily annoyed or irritated (Hostility) .62  .35  
16.   Feeling so restless you can't sit still (Anxiety) .61  .21 
  4.   Temper outbursts you could not control (Hostility) .49  .43 
14.   Spells of terror or panic (Anxiety) .48  .28 
12.   Urges to beat, injure, or harm someone (Hostility) .04  .89 
13.   Urges to break or smash something (Hostility) .12  .87 
10.   Thoughts of ending your life (Depression) .19  .67 
15.   Getting into frequent arguments (Hostility) .35  .64 
a Component I = Dysphoria 
b Component II = Hostility 
Note.  Factor loadings > .40 are in boldface.  BSI = Brief Symptom Inventory.
5
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Table 2.4.  Intercorrelations of the BSI Subscales with the PHQ-9 and MSPSS in Patients with Heart Failure 
(N = 345) 
Scale/subscale     BSI - Hostility    BSI - Depression      BSI – Anxiety  PHQ-9 
BSI - Depression    .64* 
BSI - Anxiety    .60*    .75* 
PHQ-9    .47*    .66*    .58* 
MSPSS  -.24*  -.38*   -.23*   -.35* 
Note.  BSI – Hostility = Brief Symptom Inventory Hostility Subscale; BSI – Depression = Brief Symptom Inventory 
Depression Subscale; BSI – Anxiety = Brief Symptom Inventory Anxiety Subscale; PHQ-9 = Patient Health Questionnaire-9; 
MSPSS = Multidimensional Scale of Perceived Social Support 
*p < .0001 (two-tailed)
Copyright © Lynn P. Roser 2016
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Chapter Three: Symptoms of Anxiety, Depression, and Hostility as Predictors of 
Self-Care in Patients with Heart Failure 
Introduction 
Heart failure (HF) is one of the most common chronic conditions among older 
adults in the United States.1 The incidence and prevalence of HF is increasing as more 
people live longer with cardiovascular disease.2 Between 2012 and 2030, it is estimated 
that the prevalence of HF will increase by 46%.2 Heart failure is associated with many 
physical and emotional symptoms and is one of the most frequent causes of readmissions 
to the hospital.3 Patients with HF often experience exacerbations of symptoms and cycle 
in and out of hospitals and clinics for control of these symptoms.4  
Inadequate self-care among patients with HF is the most common reason for 
hospitalization in this population.5 Optimal self-care is difficult as it is a complex set of 
activities that involves both cognitive and behavioral elements6 which patients with HF 
must learn and practice.7 Patients must learn how to maintain hemodynamic stability 
through adherence behaviors, problem solving, and management of HF symptoms.5,6 
Optimal self-care involves learning how to be adherent with medications, to follow the 
low sodium diet, to remain active and get regular exercise, as well as being engaged in 
health promotion activities such as receiving annual flu immunizations. Patients with HF 
must know how to monitor and respond to symptoms such as weight gain, edema, and 
dyspnea.4,8 While adherence to medical regimens is difficult for patients with HF, 
learning how to manage this chronic condition is even more difficult as patients must be 
actively engaged and proactive in order to make decisions concerning symptoms.7 
Patients with HF who report lower engagement in self-care have higher mortality and 
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hospitalization rates than those patients who report higher engagement with self-care.9 
Inadequate self-care and inability to engage in appropriate self-care has been 
associated with numerous factors including increasing age, female sex, lack of 
knowledge about HF, previous experience and severity of HF, lower socioeconomic 
status, poor health literacy, social isolation and poor social support, poor functional 
status, impaired cognition, and the presence of other comorbidities.10 In addition, 
symptoms of anxiety, depression, and hostility are viewed as potential barriers to 
adequate self-care, yet the data supporting the association of anxiety, depression and 
hostility symptoms with self-care are conflicting. 
Negative emotional states may influence self-care by a number of mechanisms 
(Figure 1.1). For example, patients with symptoms of depression are more likely to be 
nonadherent with medical regimens than those without depression, although not all 
investigators have confirmed this association.10,11 Patients with depressive symptoms may 
have impairments in cognition that interfere with the ability to learn and process information, 
perceive symptoms, and make decisions about their care.5 Depressive symptoms
have been shown to adversely affect functional status as well as physical activity and 
endurance, making it challenging to exercise or carry out other activities needed for 
optimal self-care.5 Individuals with depressive symptoms may view situations with a 
certain degree of hopelessness which then negatively impacts their ability to see any type 
of change in behavior or self-care as worthwhile12 
Anxiety symptoms may also influence a patient’s ability and willingness to 
engage in self-care as it alters cognition, energy, and motivation12 to learn new 
information.5,13 Cynical hostility is associated with negative views of others and self-
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reports of adopting unhealthy behaviors such as smoking.14 In addition, patients with 
negative emotional states often report feelings of social isolation and withdrawal from 
those who can offer support.12 While negative emotions have been associated with poor 
outcomes among HF patients,15-18 the exact mechanism by which they influence these 
outcomes is not fully understood.19 One proposed mechanism is that negative emotions 
negatively alter patients’ self-care behaviors (Figure 1.1). 
Accordingly, the primary aim of this study was to evaluate whether baseline 
symptoms of anxiety, depression, and hostility were predictive of self-care at 12 months 
in adults with HF while controlling for the effects of other covariates (i.e. age, sex, 
educational level, functional ability, comorbidities, and perceived social support; Figure 
1.1). Our hypothesis is that negative emotional states are predictive of poorer self-
reported self-care at 12 months. 
Methods 
Research design. This was a secondary analysis of data collected as part of a 
larger longitudinal study of patients who participated in the Heart Failure Quality of Life 
Collaborative in clinical studies at eight sites representing the Southwest, Southeast, 
Northwest, Northeast, and Midwest regions of the United States. The design, procedure, 
and results of the primary studies have been previously reported.20-23  
Participants and setting. Approval from appropriate institutional review boards 
was received prior to recruitment at all sites. Participants were recruited from community 
hospitals, academic medical centers, and outpatient clinics. A subset of 214 patients with 
complete data on the variables of interest at baseline and 12 months comprised the 
sample for the present study. Patients who did not have complete data were excluded; 
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however, there were no sociodemographic differences between those who did and did not 
have complete data. Incomplete data was the result of some sites not collecting on the 
variables of interest. Eligibility criteria were similar at all sites:  (1) documented 
diagnosis of HF associated with preserved or non-preserved left-ventricular systolic 
function and confirmed by a cardiologist, (2) ability to read and write English, (3) 
freedom from major cognitive impairment, and (4) freedom from major life-threatening 
co-morbidities which might result in death within 12 months. Patients were excluded if 
they had an acute myocardial infarction (MI) in the previous 3 months, were on a cardiac 
transplantation waiting list, were discharged to a skilled nursing facility, or were 
homeless. 
Measures. 
Anxiety. Anxiety was assessed with the Brief Symptom (BSI) Anxiety Subscale, a 
short 6-item self-report measure of anxiety.24 The BSI Anxiety Subscale includes 
statements about symptoms of anxiety such as apprehension, nervousness, tension, 
feelings of terror, and spells of terror or panic. The items within the subscale are scored 
from 0 (not at all) to 4 (extremely), with scores ranging from 0-4.25 Higher scores 
indicate higher levels of anxiety symptoms. The BSI Anxiety Subscale is a valid and 
reliable measure of anxiety24 that is easy to administer and minimizes patient burden. The 
subscale has demonstrated good internal consistency in several samples of HF patients.26-
29 Cronbach’s alpha for the Anxiety Subscale in this study was 0.83. 
Hostility. Hostility was measured using the BSI Hostility Subscale. The BSI 
Hostility Subscale is a 5-item self-report of symptoms of hostility.24 Patients respond to 
each of the 5 symptom-based items according to how bothersome hostility symptoms 
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have been during the recent past. Each item is rated on a 5-point scale of distress ranging 
from 0 (not at all) to 4 (extremely), with scores ranging from 0-4.24 The BSI Hostility 
Subscale has good internal consistency in numerous patient populations.29 as well as in 
samples of patients with HF.30, 31 Cronbach’s alpha for the BSI Hostility Subscale was 
0.77 in this study. 
PHQ-9. Depressive symptoms were measured using the PHQ-9.32 The PHQ-9 is a 
brief self-administered measure of symptoms of depression and is composed of nine 
Likert scale items that include the emotional and somatic dimensions of depression,32,33 
consistent with the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV). 
Patients are asked to rate how often they experienced each symptom on a scale of 0 (not 
at all) to 3 (nearly every day) over the course of the past two weeks; therefore, possible 
scores range from 0 to 27.33 Higher scores indicate higher levels of depressive symptoms 
and distress. The PHQ-9 has excellent reliability,32,34 and several studies support the 
reliability of the PHQ-9 in samples of patients with HF.28,35 In the present sample, the 
Cronbach’s alpha was 0.86. 
Perceived social support. Perceived social support was assessed using the self-
report Multidimensional Scale of Perceived Social Support (MSPSS).36 The MSPSS 
consists of 12 items addressing social support from three groups: family, friends, and 
significant other.36,37  Each item is rated on a 7-point Likert scale ranging from 1 (very 
strongly disagree) to 7 (very strongly agree). Total scores range from 12 to 84 and the 
three subscale scores range from 4 to 28,36 with higher scores indicating greater levels of 
perceived social support.37 The MSPSS has good reliability36-38 and has been used in 
samples of patients with HF.39-41 Cronbach’s alpha coefficient for the MSPSS total score 
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in this study was 0.94. 
Self-care. Self-care was assessed using the Self-Care of Heart Failure Index 
(SCHFI) which is a 22-item self-report that uses a 4-point Likert scale to measure three 
domains of self-care:  self-care maintenance, management, and confidence42. The self-
care maintenance subscale is comprised of 10 items, which ask questions concerning self-
care behaviors on living a healthy lifestyle, adhering to treatment regimens, monitoring 
symptoms, and weighing daily.43 The self-care management subscale is a 6-item subscale 
used to assess how well patients address and respond to symptoms of HF. Asymptomatic 
patients do not complete this subscale as it is only appropriate for symptomatic 
patients.42,43  For this reason, we did not use the self-care management subscale as we 
recruited both symptomatic and asymptomatic patients with HF. The self-care confidence 
subscale is comprised of six items concerning patients’ perceived confidence in their 
ability to engage in each self-care activity.42 The scales in each domain range from 1-4; 
the maximum score in each domain is 100 (total rating X 5), with a total possible score of 
300 points on the SCHFI if all three domain are used.42,43  Higher scores indicate better 
self-reported self-care behaviors.44  Scores below 70 are indicative of inadequate self-care 
on all the subscales.43 The SCHFI has good reliability in numerous samples of HF 
patients39,42,43,45,46 In our study, the Cronbach’s alpha for the self-care maintenance scale 
was 0.80, and for the self-care confidence scale it was 0.83. 
Functional status. We used the New York Heart Association (NYHA) functional 
classification to measure functional status.47  The NYHA functional class is based on 
numbers assigned to patients according to patients’ reports of symptoms occurring with 
physical activity ranging from I (no symptoms with regular physical activity) to IV 
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(physical symptoms of dyspnea, chest pain, fatigue, and palpitations at rest). Trained 
nurses collected this data through structured patient interviews. We combined 
classifications I and II for one group and classifications III and IV for a second group. 
Comorbid illness. We collected data on the burden of comorbid disease by using 
the Charlson Comorbidity Index.48  This standardized instrument is widely used in 
research to reflect comorbidity burden and has well-established reliability and validity. 
Trained nurses collected this information from the medical records and patient 
interviews. 
Demographic Data. Demographic data were collected on age, sex, and 
educational level through standard questionnaires. 
Data collection. Specially trained nurse researchers explained the purpose and 
procedure of the study to each participant. All patients were given time to ask questions 
and gave signed, informed consent. Trained nurses collected data through the use of 
structured patient interviews and self-administered questionnaires at baseline and again at 
12 months. Upon participant completion, the nurse researcher examined all 
questionnaires to make sure items were not inadvertently left unanswered; however, 
participants were free to leave items unanswered if they wished. 
Data analysis. Statistical analyses were performed using IBM SPSS Statistics for 
Windows (version 22.0, released 2013, Armonk, NY:  IBM Corp.). Descriptive statistics 
were computed for sociodemographic data as well as the BSI and its subscales, the PHQ-
9, the MSPSS, SCHIFI, and the Physical Subscale of the LHRQ. Hierarchical multiple 
regression modeling was used to examine the relationships between symptoms of anxiety, 
depression, and hostility with self-care confidence and with self-care maintenance, 
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controlling for covariates. The assumptions of a linear relationship between the predictor 
variables and the dependent variable, no multicollinearity, no significant outliers, equal 
error variance and normally distributed errors were tested and no violations were found. 
Statistical significance was preset at 0.05. 
Results 
Patient characteristics. Two hundred and fourteen patients with HF were 
included in the analyses of this study (Table 3.1). The majority of patients in the sample 
were white males. There was a greater proportion of males than females in the NYHA 
classification group I/II (64.7% vs. 37%). The patient sample had a mean BMI of 32.41 
(±8.55) and the majority of the sample either smoke (17.3%) or reported being a former 
smoker (42.1%). Over one-third of the patients (39.3%) reported they were retired due to 
HF or were disabled, while 27.6% of the patients reported they were employed full-time. 
At baseline, the patients in this sample had elevated levels of anxiety (0.56  
0.66) and hostility symptoms (0.44  .50) compared to the normal mean level of 0.35  
0.45 and 0.35  0.42, respectively.29  The sample population also had elevated levels of 
depression (5.03  4.90) at baseline according to scoring guidelines49 and the perception 
that their level of social support was moderate (68.86  18.11) at baseline as compared to 
suggested thresholds recommended by developers of the MSPSS.36,38  At 12 months, 
sample patients reported poor self-care maintenance (55.94  19.53) and self-care 
confidence (60.04  19.58) as shown in Table 3.2. 
Hierarchical regression. In the two separate hierarchical multiple regression 
models for self-care maintenance and self-care confidence, predictor variables were 
entered in four blocks. Demographic variables of age, sex, and level of education were 
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entered into the first block; clinical variables of NYHA functional classification and 
comorbidities were entered into the second block; MSPSS was entered into the third 
block; and the negative emotional states of anxiety, depression, and hostility symptoms 
were entered into the final block of each of the self-care behavior models. 
Self-care maintenance. The relationships between predictor baseline variables and 
self-care maintenance in patients with HF are presented in Table 3.3. In the final model, 
only age (p = .014), level of education (p = .001), and perceived social support (p = .003) 
at baseline were significant predictors of self-care maintenance at 12 months. Sex, 
NYHA functional classification, comorbidities, and symptoms of anxiety, depression, 
and hostility were not predictive of self-care maintenance at 12 months. The final model 
of baseline predictor variables and self-care maintenance was significant (F=4.619, 
p< .001). 
Self-care confidence. The final multiple regression model of baseline predictor 
variables and self-care confidence at 12 months is presented in Table 3.4. Baseline 
education (p=.039) and perceived social support (p<.001) were significant predictors of 
12-month self-care confidence among patients with HF. The other variables of age, sex, 
NYHA, comorbidities, and all three negative emotional states of anxiety, depression, and 
hostility symptoms were not significant predictors of self-care confidence at 12 months. 
The final model was significantly predictive of self-care confidence at 12 months in 
patients with HF (F= 4.334, p<.001). 
Discussion 
The results of our study provide more insight into understanding the influence of 
negative emotions and subsequent self-reported self-care behaviors. Our patient sample 
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had inadequate self-care maintenance and self-care confidence as mean scores on both 
subscales were less than 70 which is the recommended threshold for determining 
adequacy in self-care. The patient sample also had elevated baseline symptoms of 
anxiety, depression, and hostility; however, none of the negative emotional states were 
predictive of self-reported self-care behaviors. Nonetheless, increasing age, higher 
education, and higher perceived social support were predictive of better self-care 
maintenance, while higher education levels and higher perceived social support were 
found to be predictive of better self-care confidence.  
The absence of negative emotions as a significant predictor of self-care was a 
surprising finding in our study as negative emotions have been identified as barriers to 
self-care5 and associated with poor self-care in several studies.11,50  While the study 
sample had elevated baseline symptoms of anxiety, depression, and hostility, symptoms 
of these negative states were not severe as published norms.29   In addition, the mean of 
the depressive symptom measure, PHQ-9, was elevated, but below the score of 10 often 
used as an indication of clinical depression.33   This may be a contributing factor in the 
results of our study. Patients with HF who have symptoms of anxiety, depression, and 
hostility are more likely to be less adherent to medical regimens, less likely to utilize 
appropriate health-care resources, and more likely to adopt or maintain unhealthy 
lifestyles.5,51  
The results of studies on the influence of negative emotional states on self-care 
have been inconsistent. Some studies have found negative emotions (e.g. depressive 
symptoms) were associated with various behaviors indicative of poor self-care such as 
poor medication adherence, poor physical activity or adherence with an exercise 
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program, and delay in seeking medical treatment but only weakly or not associated with 
general self-care.52-54   However, Van Der Wal et al.52 found those patients who reported 
fewer depressive symptoms were more adherent to the medical regimen overall. The 
studies by Johansson et al.53 and Nieuwenhuis et al.54 reported depressed patients had 
delays in seeking medical care despite awareness of worsening symptoms; however, the 
majority of patients were adherent with the regimens. These findings are interesting in 
that they may suggest that patients may have more social support to assist in adherence to 
a medical regimen overall; however, caregivers may not be able to recognize worsening 
symptoms being suggestive of a worsening of HF until a certain threshold of immediate 
need is reach. The investigators did not address this area. 
In a cross-sectional study of 615 patients with HF, Hwang and colleagues55 
reported that depression and anxiety were associated with poor self-care; however, only 
depression was a significant predictor of self-care. In another cross-sectional study of 255 
outpatients with HF, Becker et al.51 identified depression as one of several significant 
predictors of poor adherence to medical regimens and self-care behavior. Conversely, 
Lee and colleagues56 studied whether depressive symptoms influenced trajectories of 
self-care in patients with HF over the course of six months, and reported greater 
depressive symptoms at enrollment were associated with reduced odds (0.85, p=<0.001) 
of declining self-care over time. The investigators postulated the findings of their study 
could have resulted from the fact that those patients in the trajectory that showed 
improved self-care may have also had an improvement in their depression. 56 
The influence of symptoms of depression and anxiety on self-care has been 
studied more often in patients with HF than have symptoms of hostility. Kessing et al.10 
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conducted a meta-analysis of 65 studies similar in sample and study characteristics on 
psychological determinants of self-care behaviors among patients with HF and concluded 
depression, but not anxiety, was significantly associated with self-reported self-care. 
However, despite this finding, depression was not associated with objectively measured 
medication adherence. Self-care behaviors in the cited studies included those activities 
commonly associated with self-care such as medication adherence, following the 
recommended low-sodium diet, and regular exercise. 
Further, in a longitudinal study, Bauer et al.57 examined the effects of depression 
and anxiety on adherence to medication and health behaviors in cardiac patients 
hospitalized for acute coronary syndrome, HF, or arrhythmia. The study found that 
improvement in depression was associated with better self-care at 6 months; however, 
improvement in anxiety was not. Improvements in anxiety were associated with better 
self-care only at 6 weeks. The influence of hostility on self-care behaviors in cardiac 
patients has been studied in relation to poor health habits (e.g. risky behaviors and poor 
self-care). In a longitudinal study of outpatients with stable CHF, Wong et al.58 
determined that hostility was a significant predictor of adverse events and concluded 
much of the association was moderated by poor health habits such as sedentary lifestyle 
and smoking. While HF self-care is a foundational to better health-related outcomes, it is 
clear that long-term effects of negative emotional states on self-care of HF patients 
warrants more investigation in order to fully understand the impact of these psychological 
variables on self-care and intervene appropriately. 
It is noteworthy that some of the inconsistencies reported in the literature may be 
due to the fact that the majority of studies investigating the influence of negative 
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emotions on self-care are cross-sectional in nature and only examine variables at one 
point in time. There are limited longitudinal studies examining the predictive ability of 
negative emotions on self-care over time. Our study used baseline measures of negative 
emotions and other covariates to predict self-care at 12 months. Using measures of 
negative emotional states at one point in time to predict future events do not reflect how 
negative emotions may change, fluctuate, or improve over time which may have 
influenced the outcome variable of self-care. However, a major strength to longitudinal 
studies is that they are more robust than cross-sectional studies and can infer causality 
unlike cross-sectional studies.59  
In addition, the results in our study as compared to other studies may be partially 
explained by investigators using different measures of self-care and adherence to medical 
regimens as studies do not consistently use the same measures, making comparison 
difficult.10 However, there may also be the issue of self-report bias. Patients may not 
remember correctly, or there may be bias in self-reporting as patients may overestimate 
their adherence to weight management, taking medications, dietary recommendations, 
and activity status. Nevertheless, our findings suggest there is clearly a need for more 
research in order to gain further insight and understanding of the influences of negative 
emotions on self-reported self-care behaviors. 
Our study also demonstrates the influence of other variables on self-care. We 
found higher levels of perceived social support from family, friends, and significant 
others was a strong predictor of both self-care maintenance and self-care confidence in 
our regression models. This finding supports previous work suggesting social support 
from family and others is related to higher self-reported self-care behaviors in patients 
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with HF.5,60,61 Self-care is often difficult for patients with HF as it is complex, 
burdensome, and sometimes difficult to understand and follow. Patients with HF are 
often older, may have cognitive impairment cognition, and have numerous self-care 
demands from other comorbidities (e.g. diabetes, chronic obstructive pulmonary disease, 
arthritis, and renal failure) which limits patients’ abilities to engage in self-care.7  
Adequate social support may improve patients’ adherence to medical regimens. Social 
support may influence self-care through direct support from family such as reminders to 
patients to take medications and keep medical appointments, and encouragement to seek 
medical advice when symptoms arise.5  Sayers and colleagues4 reported higher perceived 
social support was associated with better self-reported adherence to diet 
recommendations, medication, and daily weighing. DiMatteo et al.62 also suggested 
improved health outcomes may be mediated by the influence of social support on 
adherence to treatment regimens. The strong predictive ability of social support to self-
reported self-care behaviors in our study may be an indication of the moderating effects 
of social support on negative emotions and subsequent self-care; however, this 
relationship was not analyzed. 
Our findings suggest age is predictive of self-care maintenance. This is not a 
surprising finding as the majority of patients with HF are elderly, and the prevalence of 
HF increases with the aging population.2  While cognitive impairment was not a variable 
in the current study, cognitive impairment  is one of the most common comorbidities 
among elderly people with HF.63  Cognitive impairment interferes with self-care in that it 
affects decision-making ability, memory, learning, and recall,64 and is associated with 
poor HF self-care.50 In addition, elderly patients with HF often have a higher incidence of 
69 
depression and anxiety65 which also impair memory and decision-making that negatively 
influences self-care further. 
Results from our study provide additional support for educational level being 
associated with self-care maintenance and self-care confidence. The patients in our 
sample were relatively well educated with a mean of approximately 14 years of 
education, two years beyond high school. Those who had higher education had better 
self-care. One of the most important self-care activities important to good HF outcomes is 
becoming knowledgeable about the condition.7 This entails having the basic educational 
preparation to be able to understand the medical regimen, be able to read and follow 
directions on prescription medications, understand the influence of weight gain on HF, 
understand what a low sodium diet entails, and being knowledgeable about HF and what 
symptoms mean in order make decisions and seek medical help.5,7  
Self-care maintenance and self-care confidence are associated with how well 
patients with HF adhere to their medical treatment regimens and how confident patients 
with HF are in their ability to make decisions concerning symptom recognition and 
subsequent actions.31 Chen et al 66,67 reported a strong association between patients who 
had at least a high school education and greater self-care confidence and subsequent 
overall self-care as compared to those who did not complete high school. Rockwell et 
al.68 and Gonzales et al.69 both reported that higher education levels in patients with HF 
were associated with better self-care and a higher likelihood of engagement in self-care 
behaviors when compared to those with lower education. Educational level has also been 
associated with health literacy which is vital for understanding as well as decision 
making in optimal self-care of patients with HF.70  Individuals with high education (high 
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school and beyond) have higher health literacy than individuals with less education.71  In 
addition, Rockwell et al.68 suggested that education may also influence self-care in that 
higher education develops critical thinking skills that facilitate self-care behaviors such as 
setting self-care priorities and problem solving. The complex self-care regimens, often 
seen in patients with HF, combined with lack of education may contribute to poor self-
care behaviors and subsequent poor health outcomes.  
It is important to note the results of our study underscore the need to tailor 
education and management strategies to patients’ educational levels and their abilities to 
understand the complexities of adequate self-care in HF. Patients need to be taught about 
successful self-care behaviors such as adherence to medical regimens, monitoring of 
symptoms, problem solving, and what resources to utilize to prevent exacerbations and 
complications of HF. Despite our findings concerning higher educational level and 
optimal self-care, our study should not be interpreted to mean that a person who is poorly 
educated cannot be taught self-care. Teaching self-care should not be a one-size-fits-all 
approach. The process needs to be individualized to patients’ educational and health 
literacy abilities. Those with less education may need more time and practice in order to 
understand how to take care of themselves and be fully engaged in self-care.68 
Our study also found that sex was not predictive of self-care at 12 months. It is 
interesting that in society there is a belief that women take better care of themselves than 
men.72  Heo et al.73 reported differences between the sexes in factors affecting self-care. 
Older males with higher perceived control and knowledge of HF had better self-care 
behaviors than women; while women who had poorer functional status and higher self-
care confidence had better self-care behaviors than men.73  In a longitudinal study, Chriss 
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and colleagues74 reported being an older male was a significant predictor of successful 
self-care at three months. However, contrary to these findings, the majority of cross-
sectional studies reported no differences between the sexes in various aspects of self-
care.68,75-78
In addition to chronic HF, our sample Charlson Comorbidity Score was 2.95 (± 
1.82); however, we found cormorbid disease burden was not predictive of self-reported 
self-care behaviors in our regression models. Besides HF, the comorbid disease burden in 
our sample population was similar to what is observed in the general HF population.7,68  
Having a high overall disease burden has been associated with self-care as patients with 
HF who have higher comorbidity scores have poorer self-care than those with a lower 
comorbidity scores.79  Comorbidities such as diabetes, hypertension, liver disease, 
myocardial infarctions, and corpulmonale are common in patients with HF.5,51  Patients 
with HF who have other chronic illnesses have complicated regimens and are less like to 
adhere to medical regimens due to polypharmacy, confusion over symptoms related to 
having several chronic illnesses, and lack of knowledge concerning the management of 
multiple conditions.5,74 
We used the NYHA functional classification as a measure of HF symptom 
severity affecting functional status. Our model did not show that functional status was a 
significant predictor of HF self-care maintenance and HF self-care confidence. 
Intuitively, poor functional status impairs patients’ abilities to engage in appropriate self-
care due to activity intolerance. Activity intolerance along with dyspnea are the hallmark 
manifestations of HF and limit how well patients perform activities of daily living, 
exercise, cook appropriate diets, and attend needed provider appointments for follow-
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up.70,80 However, some studies have indicated that patients with HF who have worse 
symptoms and functional status perform better self-care;68,81  others suggest that 
functional impairment is a barrier to self-care.5  Over 50% of our sample had mild 
symptoms with activity (NYHA I/II) that may have affected the outcome of our proposed 
model. 
Strengths and Limitations 
A major strength of this study is its longitudinal design over a 12-month period as 
opposed to many of the existing studies on negative emotions and self-care that are cross-
sectional in design. There are limitations to this study that should be considered when 
examining the results. The majority of patients with HF in this study were males, thus 
females were underrepresented in our study. In addition, we utilized self-report measures 
of self-care behaviors that may be influenced by memory, recall or desire to viewed 
positively regarding adherence to medical regimens. Self-report questionnaires may 
introduce a bias that could over- or underestimate the existence of symptoms of HF as 
well as adherence to medication, diets, and exercise. However, the SCHFI is a valid 
instrument and its use in the HF population is well documented. 
Conclusion 
Our study provides more insight into the self-reported self-care behaviors of 
patients with HF. While our study did not support the hypothesis that symptoms of 
anxiety, depression, and hostility would be predictive of self-care, the study did 
illuminate other variables that have an important influence on self-care. Our study does 
provide more evidence that self-reported self-care behaviors among patients with HF are 
inadequate. Also evident from our study and others is that the relationships of anxiety, 
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depression, and hostility symptoms on self-care are inconsistent. Negative emotions are 
associated with poor health outcomes. However, there is a need for further research in the 
area of how negative emotional states influence patients’ abilities to take care of 
themselves. Due to the fact that self-care is one of the primary mechanisms to prevent 
poor health outcomes in patients with HF, a better understanding of how these negative 
emotions interact with self-care is needed. 
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Figure 3.1. Conceptual Framework of Relationships of Symptoms of Anxiety, 
Depression, and Hostility, Self-Care, and Poor Health-Related Outcomes 
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Table 3.1. Demographic and Clinical Characteristics of the Sample (N=214) 
Variable n (%) Mean (± SD) 
Demographic Characteristics 
Age 60.12  (± 12.1) 
Gender 
   Male 136 (63.5) 
   Female   78 (36.4) 
Educational Level 14.12 (± 3.55) 
Marital Status 
  Single/Divorced/Widowed   83 (38.8) 
  Married/Co-habitate 127 (59.3) 
Employment Status 
  Employed   59 (27.6) 
  Retired due to HF/disability    4 (39.3) 
  Retired not due to HF/unemployed by choice   58 (27.1) 
  Homemaker/other   12 (5.6) 
Smoking 
  Current smoker   37 (17.3) 
  Former smoker   90 (42.1) 
  Never smoked   86 (40.2) 
Clinical Characteristics 
LVEF 36.74 (± 14.50) 
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Table 3.1 (continued) 
Variable   n (%)     Mean (± SD) 
NYHA Functional Classification 
  Classifications I/II combined 117 (54.7) 
  Classifications III/IV combined   94 (43.9) 
Body Mass Index 32.41 (± 8.55) 
Charlson Comorbidity Score    2.95 (± 1.82) 
Medications 
  ACE Inhibitors 149 (69.6) 
  ARBs   29 (13.6) 
  Beta Blockers 192 (89.7) 
LVEF = Left ventricular ejection fraction 
NYHA = New York Heart Association functional classification 
ACE = Angiotensin converting enzyme 
ARB = Angiotensin receptor blocker 
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Table 3.2. Mean Scores of Predictor Variables related to Symptoms of Anxiety, 
Depression, Hostility and Perceived Social Support and Dependent Variables of Self-
Care Maintenance and Self-Care Confidence (N=214) 
Variable Measure Possible Range Mean Standard Deviation 
BSI Anxiety Subscale 0 - 4  0.56 ±  0.66 
BSI Hostility Subscale 0 - 4  0.44 ±  0.50 
PHQ-9 Depression Scale 0 - 27  5.02 ±  4.90 
Perceived Social Support (PSS) 7 - 84 68.86 ± 18.11 
Self-Care Maintenance (SCHFI) 0 - 100 55.94 ± 19.54 
Self-Care Confidence (SCHFI) 0 - 100 60.04 ± 19.58 
BSI = the Brief Symptom Inventory 
PHQ-9 = the Patient Health Questionnaire-9 
MPSS = the Multidimensional Scale of Perceived Social Support 
SCHFI = the Self-Care of Heart Failure Index  
7
8
 
Table 3.3. Multiple Hierarchal Regression Analysis:  Baseline Predictors of Self-Care Maintenance at 12 Months (N=214) 
Model Variable Standardized 
β 
t 
statistics 
Variable 
p value 
R2 R2 Change/ 
P value 
F 
statistics 
Model p 
value 
1 Age .189 2.881 .004 .108 .108/<.001 8.508 <.001 
Gender -0.76 -1.156 .249 
Education Level .236 3.596 .000 
2 Age .187 2.850 .005 .119 .011/.287 5.620 <.001 
Gender -.040 -.571 .569 
Education Level .238 3.509 .001 
NYHA – Two 
Classifications I/II and III/IV 
-0.83 -1.129 .260 
Charlson Comorbidity Index .102 1.427 .155 
3 Age .155 2.378 .018 .157 .038/.002 6.440 <.001 
Gender -.044 -.648 .518 
Education Level .232 3.482 .001 
NYHA – Two 
Classifications 
I/II and III/IV 
-.052 -.709 .479 
Charlson Comorbidity Index .124 1.761 .080 
Perceived Social Support .203 3.066 .002 
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Table 3.3 (continued) 
4 Age .167 2.469 .014 .169 .012/.403 4.619 <.001 
Gender -.043 -.614 .540 
Education Level .228 3.425 .001 
NYHA – Two  
Classifications  
I/II and III/IV 
-.056 -.746 .457 
Charlson Comorbidity Index .133 1.862 0.64 
Perceived Social Support .199 2.957 .003 
BSI Hostility  Subscale -.092 -1.028 .305 
BSI Anxiety Subscale .168 1.703 .090 
PHQ-9 Score (Depressive 
Symptoms) 
.060 -.647 .518 
NYHA = New York Heart Association functional classification 
BSI = Brief Symptom Inventory 
PHQ-9 = Patient Health Questionnaire-9 
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Table 3.4. Multiple Hierarchal Regression Analysis:  Baseline Predictors of Self-Care Confidence at 12 Months  (N=214) 
Model Variable Standardized 
β 
t 
statistics 
Variable 
p value 
R2 R2 Change/ 
p value 
F 
Statistics 
Model 
p value 
1 Age -.036 -.533 .594 .050 .050/.013 3.675 .013 
Gender -.097 -1.431 .154 
Education Level .191 2.827 .005 
2 Age -.025 -.367 .714 .079 .029/.039 3.572 .004 
Gender -.076 -1.057 .292 
Education Level .145 2.093 .038 
NYHA – Two 
Classifications 
I/II and III/IV 
-.135 -1.798 .074 
Charlson 
Comorbidity Index 
-.082 -1.126 .261 
3 Age -.066 -1.004 .317 .143 .064/<.001 5.750 <.001 
Gender -.081 -1.177 .241 
Education Level .137 2.041 .042 
NYHA – Two 
Classifications 
I/II and III/IV 
-.095 -1.289 .199 
Charlson 
Comorbidity Index 
-.054 -.758 .450 
Perceived Social 
Support 
.262 3.925 <.001 
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Table 3.4. (continued) 
4 Age -.102 -1.497 .136 .161 .018/.235 4.334 <.001 
Gender -.085 -1.197 .233 
Education Level .139 2.077 0.39 
NYHA – Two 
Classifications 
I/II and III/IV 
-.069 -.913 .363 
Charlson 
Comorbidity Index 
-.045 -.621 .535 
Perceived Social 
Support 
.248 3.669 <.001 
BSI Hostility 
Subscale 
.001 .008 .994 
BSI Anxiety 
Subscale 
-.146 -1.469 .143 
PHQ-9 Score 
(Depressive 
Symptoms) 
.006 .061 .951 
NYHA = New York Heart Association functional classification 
BSI = Brief Symptom Inventory 
PHQ-9 = Patient Health Questionnaire-9 
Copyright © Lynn P. Roser 2016
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Chapter Four: Trajectories of Symptoms of Depression and Anxiety are Predictive 
of Mortality and Physical Health-Related Quality of Life at 1-Year Among Patients 
with Heart Failure 
Introduction 
Heart failure (HF) is associated with manifestation of a wide range of 
psychological symptoms, although the most common are anxiety and depression. 
Presence of anxiety and depression in patients with HF is associated with poor adherence 
to prescribed therapy, increased healthcare service utilization, higher mortality, and 
poorer health-related quality of life (HRQOL).1,2 Anxiety and depression are not stable, 
but dynamic states that can worsen or improve over time, yet most research in this area 
has included only measures done at one point in time. As a consequence, little is known 
about the trajectory of anxiety and depression and the association of different symptom 
trajectories with patient outcomes. 
Background and Aims 
Anxiety and depressive symptoms are influenced by biological, behavioral, social, 
cultural, environmental, and economic factors that change over time. By exploring 
trajectories of anxiety and depression symptoms, clinicians can anticipate and identify 
those patients who are at greatest risk for adverse events, when to intervene, and whether 
changing these trajectories can ultimately change and improve health outcomes.3  
Thus the primary aims of this study were (1) to determine trajectories of 
depressive and anxiety symptoms among patients with HF at three points in time 
(baseline, 3, and 12 months), and (2) explore how these trajectories influence one-year 
cardiac event-free survival and physical health-related quality of life (P-HRQOL). We 
hypothesized that a) multiple trajectories of depressive and anxiety symptoms could be 
  
83 
 
identified, and b) trajectories of depression and anxiety would be predictive of clinical 
events and P-HRQOL at one year. 
Methods 
Design. This was a secondary data analysis in which we used longitudinal data 
from the Heart Failure Quality of Life Collaborative contributed by investigators from 
eight sites representing the Southwest, Southeast, Northwest, Northeast, and Midwest 
regions of the United States. The design, procedures, and results of the primary studies 
have been previously reported.4,5  
Participants and setting. Approval from appropriate institutional review boards 
was obtained at all sites and all participants gave signed, informed consent. Settings for 
recruitment of participants included community hospitals, academic medical centers, and 
outpatient clinics. Baseline, 3-month and 12-month data on 597 participants with 
complete data on the variables of interest comprised the sample. Patients who did not 
have complete data were excluded as not all sites collected data on the variables of 
interest. There were no sociodemographic differences between those who did and did not 
have complete data. Inclusion criteria were the following: 1) diagnosis of HF documented 
in the medical record confirmed by a cardiologist; 2) community-dwelling; 3) free of 
major cognitive impairment; 4) free of major life-threatening co-morbidities expected to 
result in death within 12 months; and 5) not on a cardiac transplantation waiting list. 
Measurements.  
Physical health-related quality of life. P-HRQOL was measured using the 
Minnesota Living with Heart Failure Questionnaire (MLHFQ) Physical Subscale. The 
MLHFQ is an HF-specific measure of HRQOL that is commonly used to assess patients’ 
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psychosocial, economic, and emotional aspects of their lives.6 This instrument has 
demonstrated adequate reliability and validity in a number of studies.7-9 The MLHFQ 
consists of an emotional subscale (5 items) and a physical subscale (8 items) and eight 
additional items not included in the subscales but contributing to the total score. The 
emotional subscale and the total summary score of the MLHFQ were not used in this 
study as symptoms of depression and anxiety are components of both scores, thus only 
the 8-item physical subscale score (ranging from 0-40) of the MLHFQ was used as the 
outcome variable for P-HRQOL. Higher scores indicate worse quality of life. 
Anxiety. Anxiety was assessed with the 6-item anxiety subscale of the Brief 
Symptom Inventory (BSI).10 The BSI Anxiety Subscale was chosen because it is a brief, 
valid, reliable, and sensitive measure of anxiety that minimizes patient burden. The BSI 
Anxiety subscale has well-documented reliability and validity in patients with HF.11 
Higher scores indicate higher levels of anxiety. 
Depressive symptoms. Depressive symptoms were assessed using the Patient 
Health Questionnaire-9 (PHQ-9).12 The PHQ-9 consists of nine items,13 each of which 
corresponds to one of nine symptoms of the major depressive disorder criteria in the 
Diagnostic and Statistical Manual of Mental Disorders-IV. The scores can range from 0 
to 27 with higher scores indicating higher levels of depressive symptoms.13 The 
reliability and validity of PHQ-9 have been demonstrated in numerous studies in various 
patient care settings12,14 as well as in patients with HF.15,16 
Event-free survival. Event-free survival was defined as the end point of time to 
first cardiac-related hospitalization or all causes of death during the 12-month follow-up 
period from baseline. Data on hospitalization or death were collected from medical 
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record review, patient/family interviews, and death certificates. In addition, patients were 
asked to keep a record of all hospitalizations. Trained cardiology clinicians blinded to 
patient status reviewed all sources of data about hospitalization and death that were then 
reviewed and confirmed by a second blinded cardiology clinician. 
Functional status. We used the New York Heart Association (NYHA) functional 
classification to measure functional status of participants at baseline through an in-depth 
interview. Participants are assigned a classification based on symptoms occurring with 
physical activity ranging from I (no symptoms with regular physical activity) to IV 
(physical symptoms of fatigue, dyspnea, chest pain, palpitations at rest). 
Comorbid illnesses. We collected data on the number of comorbid illnesses of 
study participants at baseline using the Charlson Comorbidity Index.17 The data were 
abstracted from the medical records and patient interviews by trained nurse researchers. 
Measurement of other variables. In order to completely characterize participants, 
data on the following demographic variables was collected: age, sex, and marital status. 
These data were collected during the participant interview. Clinical characteristics of left 
ventricular ejection fraction (LVEF), body mass index (BMI), and prescribed medications 
(e.g., beta blockers, angiotensin converting enzyme inhibitors [ACEI]) were collected by 
chart review and interview with participants at baseline. 
Procedure. Specially trained research nurses explained the purpose and 
procedures to participants in the study as well as the risks and benefits of participation in 
the study. After patients completed the informed consent process, they were given a 
packet of self-administered questionnaires with instructions regarding how to complete 
each questionnaire. Participants completed these assessments at baseline and again at 3 
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months and 1 year. The nurse researcher was available to all participants to assist them. 
In addition, the nurse researcher examined all questionnaires to make sure participants 
did not inadvertently leave any items unanswered; however, participants were free to 
leave items unanswered if they so desired. 
Statistical analysis. Data analyses were performed using SPSS for Windows 
(version 18.0, SPSS, Inc., Chicago, IL) and Mplus v6.0 (Muthén & Muthén, Los Angeles, 
CA). Latent growth mixture modeling (GMM) was used to identify distinct trajectories of 
change in depressive symptoms and anxiety. We used baseline, 3-month and 12-month 
measures of anxiety and depressive symptoms to develop trajectories. GMM is an 
approach to modeling that identifies distinct trajectories of change that vary around 
different means, have unique estimates of variance, and are homogenous within trajectory 
growth. Based on conditional probabilities and not absolute certainty, cases are assigned 
to the “most likely” trajectory or pattern of change over time. Changes in factors over 
time are modeled as random effects, and data need not be measured at evenly-spaced 
time intervals.18  
Our approach to model specification in GMM was based on common procedures 
put forth by Ram and colleagues.19 In each instance, we used several metrics to support 
the number of trajectories within the sample. The Lo-Mendell-Rubin adjusted likelihood 
ratio test20 parametric bootstrapped likelihood ratio test, Bayesian Information Criterion 
(BIC; Schwarz, 1978), convergence (entropy closest to 1), the proportion of sample in 
each trajectory (≥ 5%), and posterior probabilities (average probability of belonging in 
“most likely” trajectory close to 1.0) were used to compare alternative models (e.g. k vs. 
k-1 trajectories21). Mplus v6.0 was used to perform all GMM. The default method of 
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mitigating bias due to missing data in Mplus is full-information maximum likelihood 
estimation (FIMLE), which effectively handles most data that are missing at random. 
Among adults with HF, mixture modeling has been useful in identifying 
previously unobserved subgroups with respect to physical and psychological symptom 
burden22 and self-care behaviors,23 as well as medication adherence24 and cognitive 
function25 over time. An identify and associate approach to GMM was used to address 
specific aims. Accordingly, the first step was to develop separate growth mixture models 
for each symptom measure. Then GMMs that accounted for changes in both symptom 
measures over time were developed. The second step involved modeling associations 
among symptom trajectories and both 12-month event-free survival and physical health-
related quality of life. Using GMM, continuous-time survival was modeled. Associations 
between symptom trajectories and 12-month physical health-related quality-of-life were 
quantified using generalized linear modeling.26 Cox proportional hazards modeling was 
used in analysis of time to first event. 
Results 
Characteristics of the sample. Demographic and clinical characteristics of 
patients (N = 597) are summarized in Table 4.1. At baseline, the mean levels of 
depressive symptoms and anxiety symptoms were 6.42 ± 6.02 and 0.72 ± 0.84, 
respectively. At 3 months, mean levels of depressive and anxiety symptoms were 5.9 ± 
5.8 and 0.62 ± 0.78, respectively. Mean levels of depressive and anxiety symptoms were 
slightly improved at 12-month follow-up (5.66 ± 5.90, and 0.60 ± 0.79, respectively). 
Based on repeated measures analysis of variance (ANOVA), these changes in depressive 
and anxiety symptoms from baseline to 12 months were statistically significant (p < 
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0.001 and p = 0.001, respectively). 
Trajectories of symptoms of depression and anxiety. Using latent GMM, we 
identified models with 1-5 trajectories of depressive symptoms and 1-5 trajectories of 
anxiety. The best-fit model for depressive symptoms and anxiety included three 
trajectories each, allowing trajectories’ membership to interact (Figure 4.1). This result 
was supported by the Lo-Mendell Rubin Adjusted LRT test (140.861, p<0.001 for 
depressive symptoms trajectories and 83.912, p = 0.004 for anxiety trajectories) and 
parametric bootstrapped likelihood ratio test (142.53, p<0.001 for depressive symptoms 
trajectories and 88.288, p<0.001 for anxiety trajectories). The trajectories were identified 
based on observance of naturally occurring trajectories relative to severity of symptoms 
within the sample. Depressive symptoms (Figure 4.2) were divided into three trajectories 
as follows: trajectory I (‘getting better’; n=484, 81.1%), trajectory II (‘bad and getting 
slightly worse’; n=83, 13.9%), and trajectory III (‘bad and getting much worse’; n=30, 
5.0%). Anxiety symptoms (Figure 4.3) were divided to three trajectories as follows: 
trajectory I (‘getting better’; n= 398, 66.7%), trajectory II (‘stable with slight 
improvement’; n=132, 22.1%), and trajectory III (‘getting much worse’; n= 67, 11.2%). 
Trajectories of depressive and anxiety symptoms and prediction of 12-month 
physical quality-of-life. Patients characterized as belonging to the ‘bad and getting much 
worse,’ or ‘bad and getting slightly worse’ in depressive symptoms had markedly worse 
P-HRQOL at 12 months compared with those who were ‘getting better’ (Table 4.2). 
Patients characterized as belonging to the “stable with slight improvement’ and 
‘getting much worse’ in anxiety symptoms had poorer P-HRQOL at 12 months compared 
with those patients who were “getting better’ (Table 4.3). 
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Trajectories of depressive and anxiety symptoms and event-free survival. 
Patients belonging to ‘bad and getting worse’ in depressive symptoms had a higher risk of 
clinical events at 12 months compared with those who were ‘getting better’ (Table 4.4). 
However, this did not hold true for those patients in the ‘bad and getting much worse’ in 
depressive symptoms, as membership in this group was not a significant predictor of event-
free survival at 12 months. This indicated that relative to changes in depressive symptoms 
trajectory I, ‘getting better,’ patients in depressive symptoms trajectory III, “bad and 
getting much worse,’ had a comparable risk of clinical event. 
In adjusted analyses, with regard to prediction of event-free survival using 
trajectories of depressive symptoms, we controlled for age, gender, marital status, NYHA 
class, LVEF, BMI, use of ACEI, use of beta blockers, and Charlson comorbidity score. 
We found depressive symptoms trajectory II, ‘bad and getting worse,’ to be a significant 
predictor of event-free survival (Table 4.4) when compared to depressive symptoms 
trajectory II, ‘getting better.’ Depressive symptoms trajectory III, ‘bad and getting much 
worse,’ remained insignificant when compared to depressive symptoms trajectory I. The 
adjusted risk of clinical events for both depressive symptoms trajectories III and I were 
similar (Table 4.4, Figure 4.3). 
Patients belonging to ‘stable with slight decline’ in anxiety symptoms did not 
have a greater risk of clinical events at 12 months when compared with those individuals 
whose anxiety symptoms were ‘getting better’ (Table 4.5). However, patients in ‘getting 
much worse’ trajectory of anxiety symptoms did have a significantly greater risk of 
clinical events at 12 months when compared to those patients who anxiety symptoms 
were ‘getting better.’ 
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In adjusted analyses with regard to prediction of event-free survival using 
trajectories of anxiety, we controlled for age, gender, marital status, NYHA class, LVEF, 
BMI, use of ACEI, use of beta blockers, and Charlson comorbidity score. We found 
membership in anxiety trajectory II, ‘stable with slight improvement,’ was not a 
significant predictor of event-free survival when compared to patients in trajectory I 
whose symptoms were getting better (Table 4.5). However, anxiety trajectory III, ‘bad 
and getting worse,’ membership was a significant predictor of event-free survival risk 
when compared to patients in trajectory I (Table 4.5). This indicated that those patients in 
anxiety trajectory III, ‘bad and getting worse,’ had a greater adjusted risk of clinical 
events when compared to those patients in trajectory I. Those patients in anxiety 
trajectories II and I had a comparable risk of clinical events (Table 4.5, 4.4). 
Another analysis was conducted for an integrated model where depressive 
symptoms and anxiety were combined in one model with entropy of 0.919 that indicated 
a high posterior probability exceeding 90%, reflecting very low uncertainty in trajectory 
membership. This was supported by the Lo-Mendell Rubin Adjusted LRT test (<0.05) 
and the parametric bootstrap likelihood ratio test (<0.05). However, in this model the 
trajectory membership was not independent because there was a strong relationship 
between patterns of depressive symptoms and patterns of anxiety as presented earlier 
with the significant correlation between depressive symptoms and anxiety symptoms over 
time. Based on our findings, the best model is the one presented earlier with three 
separate trajectories for depressive symptoms and three separate trajectories for anxiety. 
Discussion 
The findings from this study indicate that symptoms of depression and anxiety are 
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dynamic and present as multiple unique trajectories over a 12-month period. There are 
three distinct trajectories of depressive symptoms and three distinct trajectories of 
anxiety. Our findings further demonstrate that distinct trajectories of depressive and 
anxiety symptoms over time predict P-HRQOL as well as event-free survival. This study 
is unique in that there are no studies to date in which trajectories of both depressive and 
anxiety symptoms were examined over time and the subsequent effect on health 
outcomes using latent GMM analyses was tested. Being able to identify depressive and 
anxiety symptom trajectories using a GMM approach allows investigators to discern 
trajectory classes that may not be evident with traditional growth modeling approaches. 
In the trajectories for both depressive symptoms and anxiety with the majority of 
patients, it was most common for these psychological symptoms to decrease over time. 
This is important for both patients and clinicians to understand as it helps guide potential 
therapy and provides reassurance that dysphoric states most commonly resolve. There is, 
however, an important minority of patients whose psychological symptoms do not 
resolve and may even worsen. These patients have the highest risk for poor quality of 
life, morbidity and mortality. This finding underscores the importance of monitoring 
anxiety and depressive symptoms over time. 
A few investigators have studied changes in depressive symptoms in patients with 
HF and have documented that depressive symptoms change over time as some patients 
may have persistent depressive symptoms while others may experience improvement in 
symptoms or develop depressive symptoms. In our study, we found those patients in 
trajectory II, ‘bad and getting slightly worse,’ and trajectory III, ‘bad and getting much 
worse,’ had poorer P-HRQOL. However, our study is quite different from other studies 
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that have examined the influence of depressive symptom trajectories on these health 
outcomes. Rather than using a naturalistic approach to identify symptom trajectories, 
most of the depressive symptom trajectory studies to date have included techniques that 
assign depressive symptoms trajectory according to specific trajectories determined a 
priori.2,27,28 Using this approach, possible changes in depressive symptoms may not have 
been detected due to the deterministic approach used in the analyses. Further cross-
sectional studies29-31 provide support for the negative impact of depressive symptoms on 
HRQOL at one point in time; however, these studies fail to examine how depressive 
symptoms may change over time and make drawing conclusions about the true nature of 
the impact of depressive symptoms on HRQOL challenging. 
We found those patients in depressive symptoms trajectory II, ‘bad and getting 
slightly worse,’ were most at risk of having a clinical event at one year. Other 
investigators32-34 have also demonstrated that changes in depressive symptoms were 
predictive of event-free survival. However, pre-established cut-points were used to 
determine the presence or absence of depressive symptoms and classify patients into 
groups describing subsequent changes in the depressive symptoms determined a priori. 
Depressive symptom trajectory studies and risk of clinical events are limited; however, 
other non-trajectory studies35,36 reported depressive symptoms at baseline were also 
associated with an increased risk of clinical events such as hospitalization or death. 
An interesting and unexpected finding in our study was membership in depressive 
symptoms trajectory III, ‘bad and getting much worse,’ was not a significant predictor of 
event-free survival. It is difficult to evaluate this finding in light of other studies 
determining trajectory membership a priori. The patients in this group had depressive 
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symptoms at baseline, even according to cut-points of 9 or 10 commonly used with the 
PHQ-9; however, the symptoms grew worse over time. None of the studies which we 
reviewed identified a depressive symptom trajectory which was bad at baseline and grew 
worse over the course of a year. This finding could be attributed to the small number of 
patients in that trajectory (5%); however, that proportion is considered acceptable for 
latent GMM analysis. 
Symptoms of anxiety are studied less frequently than depressive symptoms in the 
HF population. However, our study demonstrated that anxiety symptom trajectory II, 
‘stable with slight improvement,’ and trajectory III, ‘bad and getting worse,’ were both 
predictive of poor P-HRQOL and event-free cardiac survival. We did not find any studies 
of anxiety symptom trajectories which examined the influence of the symptom trajectory 
on HRQOL and event-free survival. However, we did find studies37,38 where baseline 
measurements of anxiety were predictive of HRQOL. 
Our study is unique as GMM allowed us to investigate the symptoms of a 
heterogeneous condition and identify naturally occurring trajectories or homogeneous 
subpopulations within the larger heterogeneous population of patients with HF that may 
not be apparent with traditional growth modeling. Our study adds to the understanding of 
how trajectories of depressive and anxiety symptoms change over time and influence P-
HRQOL and event-free survival as it allowed us to investigate the change in these 
symptom trajectories as they occurred naturally. 
Strengths and Limitations 
A major strength of our study is the analysis approach we used, which allowed us 
to examine a heterogeneous population and identify homogenous subgroups. In addition, 
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we had an adequate sample size for this type of analysis and controlled for major 
covariates. Potential limitations of our study include the use of self-reported measures for 
depressive and anxiety symptoms rather than diagnostic interviews for major depressive 
disorder or generalized anxiety disorder. Further, we did not have information on the 
participants’ past psychiatric history. However, we utilized trained nurse researchers who 
adhered to a rigid protocol for administering the questionnaires. In addition, we utilized 
measures for depressive symptoms, anxiety, and P-HRQOL that have well-documented 
validity and reliability in patients with HF. 
Conclusion 
Although this study cannot infer causality, the findings underscore the need for 
clinicians to assess for the presence of depressive and anxiety symptoms in patients with 
HF over time as an important area to target for interventions. The psychological state of 
patients impacts how they are managed medically. Through understanding how 
depressive and anxiety symptoms change over time, clinicians are better able to evaluate 
the therapeutic effectiveness of treatment as well as how to assist patients in taking care 
of themselves and maintaining optimal health. 
95 
Table 4.1. Clinical and Demographic Characteristics of the Sample (N=597) 
Variable n (%) Mean (± SD) 
Age  64.3 (± 12.8) 
Gender 
   Male 372 (62.3) 
   Female 225 (37.7) 
Marital status 
   Never married  40 (6.7) 
   Divorced/widowed/  215 (36.0) 
   Married/cohabitating  342 (57.29) 
Body mass index (kg/m2)  32.44 (± 9.02) 
Charlson Comorbidity Score  3.22 (± 1.76) 
NYHA Functional Classification 
   Class I 
   Class II 
 Class III 
   Class IV 
Left Ventricular Ejection Fraction 
Medications 
   ACE* 
   Beta blocker 
 62 (10.4) 
329 (55.1) 
187 (31.3) 
 18 (3.0) 
365 (61.1) 
497 (83.2) 
 38.37 (± 15.02) 
*Angiotensin Converting Enzyme Inhibitor
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Table 4.2. Linear Regression of Depressive Symptoms Trajectories Associated with 12- 
Month Physical Quality of Life in Patients with Heart Failure 
Predictor Variable  β CI  P 
Trajectory II – ‘Bad and Getting Slightly Worse’ 
Trajectory III – ‘Bad and Getting Much Worse’ 
11.6 
15.6 
 9.10 – 14.10 
11.60 – 19.70 
<0.001 
<0.001 
Overall Model (Adjusted R2 = 0.17, F= 63.6; P<0.001) 
Note: CI = confidence interval, β = adjusted regression slope coefficient; coefficients β for each trajectory are 
relative to Trajectory I, ‘Getting Better’ 
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Table 4.3. Linear Regression of Anxiety Symptoms Trajectories Associated with 12-
Month Physical Quality-of-Life of Patients with Heart Failure 
Predictor Variable β CI  P 
Trajectory II – ‘Stable with Slight Improvement’ 
Trajectory III – ‘Getting Much Worse’ 
 12.0 
 18.7 
10.14 – 13.95 
16.16 – 21.16 
<0.001 
<0.001 
Overall Model (Adjusted R2 = 0.34, F= 155; P<0.001) 
Note: CI = confidence interval, β = adjusted regression slope coefficient; coefficients β for each trajectory are 
relative to Trajectory I, ‘Getting Better’ 
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Table 4.4. Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Event-free Survival (Depressive Symptoms Model) 
Trajectory I = ‘Getting Better’ 
Trajectory II = ‘Bad and Getting Slightly Worse’ 
Trajectory III = ‘Bad and Getting Much Worse’ 
Predictor Variables Hazard 
Ratio 
 95% CI  P 
 Age 
 Female Gender 
Marital status 
  Divorced/widowed 
  Married/cohabitating 
NYHA class 
  II compared to I 
  III compared to I 
  IV compared to I 
1.02 
1.13 
1.54 
1.64 
2.37 
3.77 
2.52 
1.01 – 1.04 
0.78 – 1.63 
0.64 – 3.69 
0.70 – 3.84 
1.02 – 5.49 
1.60 – 8.89 
0.74 – 8.61 
0.003 
0.509 
0.331 
0.252 
0.045 
0.002 
0.139 
LVEF 
Use of ACE Inhibitors 
BMI 
Use of Beta Blockers 
Charlson Comorbidity Score 
Depressive Symptom Trajectories 
 Trajectory II compared to Trajectory I 
 Trajectory III compared to Trajectory I 
1.00 
1.00 
1.00 
0.87 
1.14 
2.17 
1.83 
0.98 – 1.01 
0.71 – 1.42 
0.98 – 1.02 
0.56 – 1.35 
1.05 – 1.24 
1.45 – 3.26 
0.91 – 3.68 
0.460 
0.987 
0.997 
0.549 
0.002 
<0.001 
0.088 
Final Model Overall Model (χ2 = 57.31, df. = 14; p <0.001) 
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Table 4.5. Adjusted Cox Proportional Hazards Regression Model of Variables Associated 
with Event-free Survival (Anxiety Model) 
Trajectory I = ‘Getting Better’ 
Trajectory II = ‘Stable with Slight Improvement’ 
Trajectory III – ‘Getting Much Worse’ 
Predictor Variables Hazard 
Ratio 
 95% CI P 
 Age 
 Female Gender 
Marital status 
  Divorced/widowed 
  Married/cohabitating 
NYHA class 
  II compared to I 
  III compared to I 
  IV compared to I 
1.02 
1.19 
1.45 
1.54 
2.33 
3.66 
2.52 
1.00 – 1.04 
0.83 – 1.71 
0.61 – 3.47 
0.66 – 3.59 
1.00 – 5.41 
1.55 – 8.62 
0.74 – 8.64 
0.004 
0.353 
0.405 
0.321 
0.049 
0.003 
0.140 
LVEF 
Use of ACE Inhibitors 
BMI 
Use of Beta Blockers 
Charlson Comorbidity Score 
Anxiety Trajectories 
 Trajectory II compared to Trajectory I 
 Trajectory III compared to Trajectory I 
1.00 
1.03 
1.00 
0.85 
1.13 
1.12 
2.18 
0.98 – 1.01 
0.73 – 1.46 
0.98 – 1.02 
0.55 – 1.33 
1.03 – 1.23 
0.75 – 1.69 
1.38 – 3.45 
0.430 
0.924 
0.924 
0.487 
0.005 
0.581 
0.001 
Final Model Overall Model (χ2 = 53.43, df. = 14; p <0.001) 
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Figure 4.1. Final Model of Depressive and Anxiety Trajectories using Latent Growth 
Mixed Modeling 
Final Model includes growth curves for two continuous measures (y, depressive symptoms 
and anxiety) as observed at 3 time points, each with an intercept (i) slope (s), a categorical 
variable indicating “most likely” trajectory (C), and ε which refers to latent variables. 
Trajectories of change in one variable (C1) were modeled to be associated with trajectories 
of the other (C2). 
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Figure 4.2. Final Model of Depressive Symptoms Trajectories 
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Figure 4.3. Final Model of Anxiety Symptom Trajectories 
Copyright © Lynn P. Roser 2016 
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Chapter Five: Conclusions and Discussion 
 
 
Summary and Integration 
The overall purpose of this dissertation was to determine the influence of 
symptoms of anxiety, depression, and hostility on health-related outcomes. To this end, 
three studies were conducted for the following aims: 1) provide evidence of the 
psychometric properties of the Brief Symptom Inventory Hostility Subscale as a valid 
and reliable instrument to assess the hostility symptoms of patients with heart failure 
(HF); 2) determine whether symptoms of anxiety, depression, and hostility at baseline 
predict poorer self-reported self-care at one year among patients with HF; and 3) describe 
trajectories of anxiety and depressive symptoms among patients with HF across three 
points in time (baseline, 3 and 12 months) and explore whether these symptom 
trajectories predict one-year cardiac event-free survival and P-HRQOL. 
Since the mid 19th century, the biomedical model (BMM) provided the traditional 
foundation for research on the understanding of disease and its treatment in the human 
body. The BMM focused on disease as a departure from a normal healthy state of the 
human body and therefore promoted a mechanistic approach to the treatment of disease.1 
This approach to the treatment of disease still dominates the medical practice of most 
providers.1 This model works well with the treatment of an infectious disease but doesn’t 
work as well with chronic diseases and conditions that are increasing in prevalence due to 
an increase in the elderly population and increase in people with chronic illnesses. The 
true nature of health is more than just the absence of disease as posited by the BMM.  
The World Health Organization (WHO) defined health as “a state of complete 
physical, mental and social well-being and not merely the absence of disease or 
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infirmity.”2 This definition served as an impetus to develop a more integrated and holistic 
approach to human behavior, illness, and disease – the biopsychosocial model (BPSM).1 
The BPSM views health and illness as a consequence of the interplay of biological, 
psychological, and social factors and how these factors influence the course and 
treatment of disease and illness.1 Subsequently, fields such as medicine, psychology, and 
nursing have utilized an interdisciplinary approach to patient care, especially in the care 
of individuals with chronic conditions such as HF. This shift in paradigm has resulted in 
medical providers understanding the importance of looking not only at illness and 
disease, but also understanding the influences of social and psychological variables such 
as negative emotional states on health-related outcomes in chronic conditions such as HF. 
Patients with HF suffer troublesome physical and psychological symptoms which 
adversely affect the quality of their lives and result in poor health outcomes.3 Negative 
emotions such as anxiety, depression, and hostility, are prevalent in patients with HF.3-5 
Research has demonstrated that patients with HF who have negative emotions are more 
likely to die or have adverse cardiac events compared to patients without negative 
emotional states.6 Practitioners need to be able to recognize and treat these negative 
emotional states early and throughout the course of medical treatment to reduce the risk 
of adverse effects and optimize the health and well-being of patients with HF. Besides 
pharmacotherapy, recent studies have demonstrated that interventions such as cognitive 
behavioral therapy,7,8 as well as stress reduction9 and counseling,10 have been effective in 
reducing negative emotional states in patients with cardiac conditions and HF and 
improving health-related outcomes. However, in order to design and test interventions, 
more research is needed to elucidate how negative emotions interact, change, and 
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subsequently influence health-related outcomes in patients with HF. 
Symptoms of anxiety, depression, and hostility have been studied extensively in 
the general cardiovascular population. However, of the three negative emotional states, 
hostility has been studied less frequently than symptoms of anxiety and depression in 
patients with HF. The conceptual definition of hostility is challenging as hostility is also 
used interchangeably with anger and aggression, both of which are behaviors commonly 
seen with hostility. For example, Chida and Steptoe11 conducted a meta-analytic review 
of studies examining the association between anger and hostility and coronary heart 
disease (CHD). The 25 studies examined by the investigators included different measures 
of hostility, trait anger, anger control, anger-out, anger reaction, anger temperament, 
anger suppression, cynical hostility, anger symptoms, behavioral hostility (interviews), 
and aggression. While the investigators concluded the studies examined in the meta-
analysis provided support that anger and hostility are associated with CHD outcomes, 
their review also demonstrated how problematic and challenging the concepts of hostility 
or anger may be when evaluating studies and associated cardiac outcomes. It is 
noteworthy that some investigators12 have begun examining both anger and hostility 
along with anxiety and depressive symptoms due to the overlapping effects of related 
affective traits. These negative emotions tend to cluster in individual patients;13 therefore, 
research investigating these psychological variables may help identify patients at risk for 
early intervention. While there are numerous measures of hostility available for 
researchers, the psychometric properties of the Brief Symptom Inventory (BSI) Hostility 
subscale have not been examined in the HF population. I thought it important to validate 
this instrument as measurement burden in HF patients is a concern, and the BSI Hostility 
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subscale is short, easy to understand and can be completed in 1-2 minutes. 
Thus, Chapter 2 is an evaluation of the psychometric properties of the BSI 
Hostility Subscale in patients with HF. Cross-sectional data were collected from a subset 
of 345 patients with HF as part of a larger longitudinal study of 1,136 patients in nine 
clinical trials throughout the United States. The Cronbach’s alpha for the BSI Hostility 
Subscale was .77 indicating good internal consistency among the five items comprising 
the subscale. The inter-item correlation coefficients for the BSI Hostility Subscale ranged 
from .30 to .78, indicating adequate homogeneity. The BSI Hostility, Anxiety, and 
Depression Subscales were subjected to principal component analysis (PCA) followed by 
exploratory factor analysis (EFA). These analyses, as well as examination of the scree 
plot, supported a two-dimensional structure within the three subscales of the BSI: Factor I 
(Dysphoria) and Factor II (Hostility). I hypothesized the BSI Hostility Subscale would 
have a positive correlation with the BSI Depression and Anxiety Subscales and PHQ-9 as 
well as a negative correlation with the MSPSS, indicating patients with greater hostility 
levels would have greater levels of depressive and anxiety symptoms as well as poorer 
perceived social support. The findings of my study demonstrated there was a moderate to 
strong positive correlation between the BSI Hostility Subscale and the BSI Anxiety and 
Depression Subscales as well as the PHQ-9. In addition, there was a weak, negative 
correlation between the BSI Hostility Subscale and the MSPSS. These findings supported 
my hypotheses and initial support for the psychometric soundness of the BSI Hostility 
Subscale as a measure of hostility in patients with HF.  
Patients with HF who have negative emotional states often have poor self-care 
behaviors and fail to adhere to medical treatment regimens such as taking prescribed 
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medications,5,14-21 following a prescribed low-sodium diet, exercising,22 monitoring for 
symptoms, and making sure they weigh themselves daily.23 In addition, patients with 
symptoms of anxiety, depression, and hostility often continue or adopt risky behaviors 
such as smoking,24,25 sedentary lifestyle, and poor diets.19,25-29 Depressed, anxious, or 
hostile patients may not utilize available resources appropriately such as attending 
cardiac rehabilitation and may miss or fail to seek needed clinic appointments and 
follow-ups.23 As a point of fact, inadequate self-care behavior has been shown to be the 
most commonly cited reason for hospital readmissions among patients with HF.30 
Subsequently, developing strong self-care behaviors in patients with HF is viewed to be 
the cornerstone to preventing exacerbations of symptoms and improving health-related 
outcomes (i.e. QOL, hospital readmissions, and mortality) in this population.31,32  
Many of the studies examining the influence of negative emotional states on self-
care are cross-sectional in design.33,34  Studies report negative emotions are associated 
with poorer self-care behaviors. While cross-sectional studies are economical, allow for 
collection of a large amount of data over a shorter period, and are easily reproduced, 
investigators are limited to making observations to one point in time.35 Cross-sectional 
studies do not allow investigators to make a temporal association between negative 
emotions and self-care behaviors; therefore investigators may be able to demonstrate 
association but not causality.36  
Conversely, longitudinal studies have the advantage of inferring causal 
relationships that cross-sectional studies are unable to do as repeated measurements on 
the same individuals are gathered over a long period of time.37 Longitudinal study 
designs have the ability to demonstrate progress and change in variables of interest and 
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show clear patterns over time.37 Disadvantages of longitudinal studies include the 
possibility of drop-out of participants over time and the fact that they are more expensive 
and labor-intensive than cross-sectional studies.37 Several longitudinal studies have 
demonstrated that negative emotions are predictive of self-care behaviors.19,38 However, 
results have been inconsistent in the literature. Some studies have shown negative 
emotions were associated with specific self-care behaviors such as medication adherence 
and exercise, but not associated with general self-care.39-41 Clearly there is a need for 
more longitudinal studies investigating the long-term effects of negative emotions on 
self-care and how providers may intervene to support adequate self-care in patients with 
HF. 
Chapter 3 is a secondary data analysis of longitudinal data to determine whether 
baseline symptoms of anxiety, depression, and hostility were predictive of self-care at 12 
months in patients with HF. I identified a subset of 214 patients with HF enrolled in a 
larger longitudinal study representing the Midwest, Southwest, Southeast, Northwest, and 
Northeast regions of the United States with complete data on the variables of interest. 
Hierarchical multiple regression was utilized in the analysis of the data. Baseline 
measures of anxiety, depression, and hostility symptoms were entered into the model 
along with covariates identified from the literature (i.e. age, sex, educational level, 
functional status, comorbidities, and perceived level of social support). The study did not 
show that baseline negative emotional states were predictive of self-reported self-care 
maintenance and self-reported self-care confidence at 12 months. However, baseline age, 
level of education, and perceived social support were significant predictors of 12-month 
self-reported self-care maintenance, and baseline level of education and perceived social 
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support were significant predictors of 12-month self-reported self-care confidence. 
The results from my study may be due to the fact that a repeated measures design 
was not implemented and only baseline measures of anxiety, depressive, and hostility 
symptoms were used as predictors of self-reported self-care maintenance and self-
reported self-care confidence at 12 months. The nature of negative emotions is that they 
are dynamic and change over time. Failure to find a significant relationship between 
negative emotions and self-reported self-care may be attributable to the fact that patients 
did not continue to have symptoms of anxiety, depression, or hostility for the duration of 
the study.42 Being able to look at the trend or trajectory of negative emotional states on 
self-care over time may be more revealing. 
Trajectory studies in patients with HF have demonstrated depression is predictive 
of poor health-related outcomes.43-45 However, these studies used subgroups identified a 
priori in examining the predictive ability of negative emotions on health-related 
outcomes.  In the study described in Chapter 4, I chose to use latent growth mixture 
modeling in order to identify distinct subgroups that may be obscured using traditional 
methods. 
Chapter 4 is an analysis of trajectories of anxiety and depressive symptoms over 
12 months and evaluation of whether these trajectories across three points in time 
(baseline, 3 and 12 months) were predictive of event-free survival and P-HRQOL at 12 
months in patients with HF. Data from a subset of 597 patients with HF enrolled in a 
larger longitudinal study was used in the analysis. I used latent growth mixture modeling 
to identify unique trajectories of symptoms of anxiety and depression in the patient 
sample and Cox linear regression models to determine whether these negative emotions 
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were predictive of event-free survival and P-HRQOL. Results of the study demonstrated 
the majority of patients’ anxiety and depressive symptoms got better over time. However, 
the study also demonstrated that unique trajectories of anxiety and depressive symptoms 
were predictive of event-free survival and P-HRQOL. However, an interesting finding in 
the study is that the worst trajectory of depressive symptoms was not predictive of event-
free survival at 12 months in patients with HF. These findings may be the result of the 
small number of patients in that trajectory of depressive symptoms although the number 
was sufficient for the trajectory analysis. 
Impact of Dissertation on the State of Science 
The findings of this dissertation filled some gaps in understanding how anxiety, 
depression, and hostility symptoms influence health-related outcomes of patients with 
HF. Negative mood states most often studied in relation to health outcomes in patients 
with HF are symptoms of anxiety and depression. Hostility has been studied extensively 
in relation to its influence on the development and progression of CAD but not as 
extensively in the HF population. Patients with HF often report higher levels of multiple 
negative emotional states,46 yet these states are often not recognized or treated 
adequately.10,47-49 In addition, many studies examine symptoms of anxiety, depression, 
and hostility apart from each other; however, associations of multiple affective traits with 
cardiovascular disease overlap.12 Symptoms of these negative emotional states often 
overlap.23 Individuals with depressive symptoms are often anxious, individuals with 
anxiety often have depressive symptoms,23,50 and individuals with symptoms of hostility 
often demonstrate high levels of annoyance and irritability seen in anxious states. 
Therefore, it is important to examine all three negative states to understand their 
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prevalence, how they interact and fluctuate over time, as well as their relationships to 
health outcomes.  
In Chapter 2 I advanced the state of science in the literature by evaluating the 
validity and reliability of the BSI Hostility Subscale in patients with HF. Most of the 
measures for symptoms of hostility are lengthy11,51 and may create an undue burden on 
patients with HF who often report high levels of fatigue.52,53 The BSI Hostility subscale is 
a short five-item subscale, does not create undue burden on patients, and has been used in 
several studies in the HF population. However, there are no studies in the literature 
evaluating the psychometric properties of this measure in patients with HF. Thus, this 
study is the first to provide psychometric support for the BSI Hostility Subscale as a 
sound measure of hostility in HF patients.54,55 In addition to psychometric support for the 
BSI Hostility Subscale, suggestions for improvement in wording on items in the Subscale 
were made that may be useful in future studies.  
The longitudinal study described in Chapter 3 advances the state of science in 
evaluating how predictive baseline measures of anxiety, depression, and hostility 
symptoms are relative to self-care at 12 months. There are limited longitudinal studies 
examining the influence of negative emotions on self-care,56 as most studies are cross-
sectional and offer inconsistent results. My study did not provide evidence that baseline 
measures of negative emotions are predictive of self-care. However, the results do 
provide support for the contribution of age, educational level, and, more importantly, 
perceived social support in predicting self-care. These findings are consistent with other 
studies. In addition, the study does offer more insight into the relationship of negative 
emotions on self-care. The patients in my study had mild elevations of negative 
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emotional states, yet these states did not influence future self-care significantly. This 
finding provides some evidence that negative states may need to be above a certain 
threshold in order to be an important predictor of future self-care and provides evidence 
that interventions aimed at increasing social support may result in better self-care 
behaviors in patients with HF. Despite the lack of significant findings on the contribution 
of negative emotions influencing self-reported self-care behaviors, the study does 
underscore that patients with HF have elevated levels of negative emotional states that 
should be routinely assessed in order to target interventions aimed at improving self-care 
and health outcomes. 
Lastly, in Chapter 4, I advanced the state of science by identifying and evaluating 
how trajectories of symptoms of anxiety and depression may predict P-HRQOL and 
event-free survival at 12 months. This is a very important study in several ways. First, to 
my knowledge, this is first study of patients with HF that has utilized latent growth 
mixture modeling in evaluating the predictive ability of trajectories of negative emotions 
and future health outcomes. In general, there are limited studies evaluating trajectories of 
negative emotional states on health outcomes, and those that do exist have used 
deterministic approaches where trajectories are pre-determined at set cut-points and 
patients are then grouped into those categories. Secondly, this study demonstrated how 
negative emotions actually fluctuate over time to influence health-outcomes. I identified 
three distinct trajectories of these symptoms of anxiety and symptoms of depression. 
While the majority of patients had improvement in symptoms of over the course of one 
year, those patients whose symptoms worsened over time had worse P-HRQOL and more 
cardiac related events. Lastly, this study adds to our understanding of how negative 
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emotional states truly change over time naturally and how studies using a deterministic 
approach may not capture how these fluctuations actually influence health outcomes. For 
example, if using a cut-point of 10 (commonly used for determining the presence of 
depression)57 in the PHQ-9, I would not have been able to identify the two significantly 
distinct trajectories of depressive symptoms that worsened over time that subsequently 
revealed different outcomes in my study. One was predictive of event-free survival, while 
the very worst trajectory of depressive symptoms was not. The findings in this study 
demonstrate how negative emotions change over time (baseline, 3 and 12 months) and 
emphasize the importance of routine assessment of anxiety and depression symptoms. 
Through routine assessment of negative emotional states, clinicians may monitor efficacy 
of treatment and intervene earlier to improve symptoms, slow the progression of HF, and 
subsequently improve future health-related outcomes.  
Recommendations for Nursing Practice and Research 
Negative emotional states are important predictors of health-related outcomes in 
patients with HF such as poor P-HRQOL, increased hospital admission, and increased 
mortality. Increased levels of anxiety, depression, and hostility symptoms are more 
common in cardiac patients than in healthy individuals.46 As a result, negative emotional 
states in patients with HF need to be assessed routinely over time to detect their presence 
as well as need for intervention.  
In order to assess the presence of negative emotional states, clinicians need to be 
able to use psychometrically sound measures that are easy to administer and brief, 
without being burdensome to patients with HF. There are numerous tools available to 
measure hostility, and each vary in their psychometric properties and clinical utility.11 
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While this dissertation has provided initial support for the soundness of the BSI Hostility 
Subscale, more studies need to be conducted in order to replicate the results of this study 
and support the Subscale’s reliability in the heart failure population. 
Negative emotional states are a barrier to engaging in appropriate self-care 
behaviors.23 Patients who have symptoms of anxiety, depression, and hostility have poor 
adherence to medical regimens, as well as adoption or continuance of unhealthy lifestyle 
practices (i.e. smoking, unhealthy diets, lack of exercise).24,25,58-64 In addition, negative 
emotions are often associated with poor use of appropriate resources such as keeping 
scheduled clinic appointments and cardiac rehabilitation23,65 as well as social isolation 
and poor social support.23,65-68  
The study outlined in Chapter 3 did not support my hypothesis that baseline 
negative emotional states would be predictive of self-reported self-care at 12 months; 
however, results demonstrated social support was a significant predictor of self-care and 
a potentially strong mediator of the relationship between negative emotions and self-
reported self-care behaviors. This is an important finding as social support has been 
shown to aid in the ability of HF patients to care for themselves23,32 as well as act as a 
means to cope with the stress of having a chronic illness.69 Patients with symptoms of 
anxiety, depression, and hostility often report poor social support.70,71 The presence of 
negative emotional states and poor social support among HF patients has been shown to 
be predictive of poor outcomes and higher risk of events.72 Most of the studies 
investigating the relationships between negative emotions and self-care are cross-
sectional in design and present inconsistent results. The implication from my study as 
well as others in the literature is that more longitudinal studies need to be conducted to 
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examine the relationships of negative emotions on self-care behaviors.  
In addition, the study described in Chapter 4 is novel in that the analyses utilized 
latent GMM to identify unique trajectories of anxiety and depressive symptoms that were 
found to be predictive of P-HRQOL and event-free survival. It is my belief that this type 
of analysis is more robust than using a deterministic approach. However, due to the novel 
application of latent GMM used in this study, more studies using this type of analysis are 
needed to determine whether the findings can be replicated.  
The studies in this dissertation did not involve examination of any interventions 
aimed at improving negative emotional states, self-care, or health-related outcomes. 
However, the studies in this dissertation do serve as an impetus to investigate non-
pharmacological interventions targeting negative emotional states and self-care 
behaviors. One such therapy that holds promise for improving health outcomes is 
cognitive behavior therapy that encourages cognitive reappraisal. Individuals with 
negative emotional states appraise situations according to motivational relevance and 
congruence related to their goals; therefore, they may view and respond to events 
differently.73 Cognitive reappraisal may improve symptoms of anxiety, depression, and 
hostility and assist patients with HF in making behavior changes that improve self-care 
and health-related outcomes.  
In summary, implications of this dissertation include the importance of 
monitoring negative emotions over time as well as the need for further longitudinal 
studies that examine relationships between negative emotions and health-related 
outcomes. A better understanding of how psychological symptoms change is meaningful, 
as it affords clinicians the opportunity for timely interventions designed to reduce the risk 
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of adverse events and improve health outcomes. In order to achieve this, further research 
is needed to investigate psychological symptom trajectories and identify high-risk groups. 
In addition, the design and testing of interventions aimed at reducing psychological 
symptoms is critical to improve health outcomes in patients with HF.  
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